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“Every human being of adult years and sound mind 
has a right to determine what shall be done with his own 
body.”  
– Justice Benjamin Cardozo (in Schloendorff v Society of 












                                                          
2 Back in 1914, case law established the requirement that health professionals obtain a patient’s consent for 
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Purpose of the research 
Over the last decades, there have been significant efforts to institutionalize advance directives, 
not only by legal means, but also by educational and public policy implementation means. In 
the United States (US), all fifty states and the District of Columbia have had specific legislation 
authorizing and regulating the use of these instruments for a long time. The Federal Patient 
Self-Determination Act (PSDA) enacted in 1990, requires all health care providers to inform 
patients of their rights under state law to make medical decisions and to execute advance 
directives. In Portugal, the Living Will Law, which regulates specifically these directives, has 
been in force since 2012, with its applicability still being tested in practice. Portuguese views 
about death influenced by Catholicism may be a significant obstacle to the implementation and 
use of these medical directives. In contrast, Macau has neither statute nor case law on the legal 
status of advance directives. Few Chinese are familiar with the concept of end-of-life planning. 
Chinese rooted in Confucianism often see death as a taboo and do not like to talk about it. 
Family members also affect the decision-making process and the execution of advance 
directives. 
Since the 1960s, developments in medical technology have enabled physicians to extend 
surgical services and medical treatments, giving men unparalleled power to combat disease, 
leading to situations where life can be artificially extended. This resulted in the development of 
advance directives and more recently the advance care planning concept to address new kinds 
of end-of-life choices faced by individuals and families. Another impact of advances in medical 
technology is on health care costs. Modern technology is expensive. In addition, as the 
population continues to age, it is inevitable that health care costs, particularly at end of life, will 
continue to escalate at an unsustainable pace. Moreover, costs of caring for patients with long-
term chronic diseases, like HIV/AIDS and cancer, also represent a large economic impact from 
society’s point of view.   
Evidence suggests that physicians and patients should engage in advance care planning in order 
to help ensure that medical treatment decisions are in accordance with the patient’s 
wishes/values. However, if advance directives were implemented with the main goal of 






that they can at the same time be effective in curbing rising health care costs? Research studies 
have revealed that savings are less that most people anticipate. A number of controversial issues 
around advance directives and end-of-life decisions remain unsettled, as medically appropriate 
care should never be withheld solely because of costs.  
While these directives enhance patient autonomy in health care decision-making, in 
contradiction to a typical medical paternalism, presently health is a scarce resource. In Portugal, 
one of the main European countries hit by the economic crises, the social right to health can be 
extremely costly for the government. As such, several measures for rationing health resources 
have been recommended since the bailout3. There has been increased concern about how to 
reconcile this social right protected by the Constitution with the principle of economy in the 
delivery of public services4. Unfortunately, there may be an appetite for cutting medical costs 
that might jeopardize the rationale of advance directives, as they may easily be seen as or 
converted to an explicit tool for cost saving and rationing medical care at the end of life. Should 
that occur, it may be deemed too costly to society and to the health care system, as ethical 
dilemmas may arise.  
Chapter One of the present work focuses on the development of advance directives starting with 
their rationale, followed by their historical evolution in the US. It also examines advance care 
planning and its tool POLST as a new communication paradigm that emerged more recently in 
the US, with its perceived benefits. Chapter Two makes a comparative analysis with the 
Portuguese legal framework on advance directives and refers also to my Macanese experience. 
Because law is not completely detached from each country’s cultural background, this chapter 
examines the differences between these world regions, in terms of cultural mind-sets and 
demands, and how can they affect the implementation of advance directives, thus, enabling a 
multidisciplinary and transnational approach. Chapter Three is about the economics of dying. 
From the US SUPPORT study to more recent studies, this chapter discusses the effectiveness 
of advance directives and advance care planning in terms of reducing health care costs. It further 
covers the ethical implications of advance care planning becoming a purely economic strategy. 
As the US legal framework is far more developed than in other countries in the health care field 
and in the specific topic of advance care, Chapter Four is dedicated to the lessons and 
                                                          
3 BARROS, PP et al. (2016); OECD (2015).  






recommendations we can take from the American model considering the current state of affairs 
of Portugal and Macau. The Conclusion offers a few final thoughts.  
CHAPTER ONE 
DEVELOPMENT OF ADVANCE DIRECTIVES  
1.1 The Rationale  
Advance directives have long been advocated as a principal means to maximize patient’s 
autonomy and control over relevant medical decisions in the end-of-life context5. Until the 
1970’s, traditional medical practice was predominantly doctor-centered, based only in the 
expert opinion of the physician, who made the decisions considering what they thought best for 
the patient without regard to the patient’s individual preferences and needs6. 
The directives grew out of the patient and consumer rights movements that started on the 1960’s 
and 1970’s7. Their need arose in a time of great technological developments in science and 
medicine8, radically changing the practice of Western medicine. The introduction of new life-
sustaining equipment and expertise brought new medical problems, as patients may survive 
longer and treatment may become futile. There was also a significant increase in medical 
awareness9. Patients gained easier access to medical information, reducing the informational 
gap that typically characterizes this relationship10.   
Hence, scholars typically frame the rationale for these directives in terms of autonomy11,12. 
They emerged as an important tool to enhance patient autonomy and to guarantee that a person, 
if incapacitated in the future as a result, for example, of illness, injury, dementia or persistent 
vegetative state, may still make autonomous health care decisions. These instruments allow 
patients to consent to or refuse any medical treatment, namely, but not only, if excessive, 
                                                          
5 SULLIVAN, R et al. (2015). 
6 DONG, R (2011). 
7 LAMERS (2005). 
8 E.g., Engstrom Universal Respirator (Model 150) was introduced in 1954 (at: 
https://www.woodlibrarymuseum.org/.../engstrom-model-150). 
9 ANTUNES, JB (2010), pp.18-19. 
10 WEISS, GB (1985). 
11 SABATINO, CP (2010), p.219. 






disproportionate or futile. This is related to the principle of beneficence for the patient, which 
is the duty to do good, and the principle of non-maleficence, which means to do no harm13. 
Decision-making is a complex process14 and can be problematic at end-of-life when an 
individual becomes incompetent due to illness or age. 
The living will, a document by which a patient states what treatments he or she would want at 
the end of life, was created originally to help prevent unwanted and invasive medical care at 
the end of life. It attempts to ensure that patients receive the treatment they want, promoting 
patient-centered care.  
The health care power of attorney is a document in which the patient names an individual to 
make medical decisions when he or she is incapacitated and unable to do so. The rationale is to 
guarantee that health care decisions are made by someone patients trust in the event they 
become incapacitated.  
The focus on patient’s autonomy and right to self-determination is concomitant with a decline 
in or abandonment of medical paternalism15. This shift of paradigm in contemporary biomedical 
ethics towards a more interactive model, based on an ongoing dialogue and exchange of 
information, allowed patients to be active protagonists in their health care decision-making 
process, embracing a patient-centered approach. Thus, physicians should follow prior expressed 
wishes of adult competent patients, as they must be respected and take priority in relation to the 
doctor’s technical opinion16.  
With the idea of paternalism in medicine becoming unpopular, autonomy or self-government, 
as its antithesis, is considered one of the ethical bases of the law of advance directives. 
Beneficence and non-maleficence, as stated above, equity and veracity, the foundation of 
informed consent in patient care, are also considered to be the basis of these directives.  
 
                                                          
13 THORNS, A (2010). 
14 LINDA, E AND SCANDRETT, KG (2010). 
15 SERRÃO, D (1997). 






                                                          
17 DETERING, K AND SILVEIRA, MJ (2017). 
18 GUNTER-HUNT et al. (2002). 
19 DETERING, K AND SILVEIRA, MJ (2017). 
20 GUNTER-HUNT et al. (2002). 
22 At: https://www.njsharingnetwork.org/document.doc?id=199. 




A document by which a patient while still capable expresses his or her 
wishes about the type of medical treatments or life-sustaining 
measures he or she wants or does not want if his or her condition 
becomes medically hopeless (i.e., when medical interventions will do 
nothing more than artificially delaying the moment of death). It goes 
into effect once a physician (sometimes more than one) determines that 
the patient is in a particular medical condition set out in the law, such 
as a persistent vegetative state, advanced dementia or terminal illness, 
and is unable to communicate his or her own wishes regarding medical 
treatment17,18. It covers only situations where the patient has an end-
stage medical condition or is permanently unconscious. In North 
Carolina, for example, the living will is a declaration of the patient’s 
preferences and wishes for a natural death. Normally, this directive 
does not go into much detail in terms of treatments patients may choose 
to withdraw or maintain. Treatments can vary from cardiopulmonary 
resuscitation, artificial nutrition and hydration, mechanical ventilation, 








A document by which a patient gives someone else, named health care 
agent or proxy (also referred to as surrogate), the power to make 
medical decisions on his or her behalf when he or she becomes 
incompetent (i.e., mentally or physically incapable to do so)19,20. In 
contrast to the living will, which deals exclusively with end-of-life 
care, the health care power of attorney allows the patient to give 
powers to the proxy in a wide range of medical decisions. As the 
patient’s appointed health care agent may make a broad range of 
medical decisions on the patient’s behalf, it is important that such 
person knows the patient’s wishes. Although the proxy need not be a 
family member, it should be someone the patients totally trusts. To 
appoint a second or alternate proxy is normally advisable in case the 
primary appointed one is unavailable to make the decision when the 
time comes or resigns. 
Combination 
of features of 
both the 
proxy and the 
instruction 
Patients may want both to give written instructions about medical 
treatment preferences and to appoint a health care proxy to make sure 
that such instructions are followed and honored. For example, in New 






















                                                          
21 DETERING, K AND SILVEIRA, MJ (2017). 
23 At: https://www.agingwithdignity.org/. 
24 At: https://www.psychiatry.org/news-room/apa-blogs/apa-blog/2016/12/psychiatric-advance-directives-
planning-for-mental-health-care. 
25 DETERING, K AND SILVEIRA, MJ (2017). 
26 MEEHAN, F (1991), p.144. 
27 YUEN, JK et al. (2011), p.791. 
directive in a 
single 
document21 
care. Another form, called Five Wishes23, is also an example of a 
combined directive template. This one was created by a private non-
profit organization called Aging with Dignity. It is not a state-
sanctioned document, and its most notable feature is that it addresses 
more comprehensively other important elements related to comfort 
care and spirituality. It is used in many health care facilities in the US 
to promote a family discussion about end-of-life issues, often along 









A relatively new tool to deal specifically with mental health decisions 
in advance. By executing this directive, patients inform medical 
providers about their specific preferences for future mental health care 









These are medical orders prepared by the physician at the request of 
the patient. There are in-hospital and out-of-hospital DNR orders, 
depending on whether the patient is hospitalized or living at home or 
in a hospice25. A DNR order is done by a physician and states that 
resuscitative measures should not be performed on the patient in the 
event a patient suffers from a cardiopulmonary failure26. The goal of 
this medical order is also to promote patient’s self-determination and 
avoid non-beneficial interventions27. With more states implementing a 
universal type of DNR order, this tool allows patients to express what 
they want in terms of resuscitation while being transported from one 






1.2 US history of Advance Directives  
Considering the strengthening of the patient’s right to self-determination and autonomy, in the 
last decades there have been ongoing efforts to institutionalize advance directives. The US was 
the leading country, where the living will was first proposed and described by Luis Kutner in 
1969. According to this human rights lawyer from Illinois, “Th[is]document would provide that 
if the individual’s bodily state becomes completely vegetative and it is certain that he cannot 
regain his mental and physical capacities, medical treatment shall cease.”28. 
From this initial proposal, it took not even ten years until advance directives were officially 
inaugurated in 1976 with California’s adoption of the first living will statute, The Natural Death 
Act, also known as Death with Dignity Act, which took effect in January 1, 1977. For the first 
time in history, there was a law that allowed patients to direct their physicians to withhold or 
withdraw life-sustaining treatments in the event of a terminal illness or permanent 
unconsciousness when death was imminent. Moreover, this document gave physicians statutory 
protection if they followed the patient’s wishes in good faith. This first statutory document was 
perhaps the most recognized and available living will29. Appendix 1 sets out the text of the 
original California law.  
Even though the California Natural Death Act was praised for its contribution to raising public 
awareness of the principle of autonomy30, much public controversy and political debate affected 
its final version. The statute was criticized for containing ambiguous language and terminology, 
creating interpretation problems and bureaucratic burdens for physicians and patients. It was 
considered of very limited applicability.31 Opponents also claimed it was not comprehensive 
and was overly formalistic32. One commentator remarked that the statute had only symbolic 
value33.  
Additionally, by establishing a statutory right to be allowed to die, there was the risk of opening 
the door to involuntary euthanasia (mercy killing)34. It should be noted that the California statute 
                                                          
28 KUTNER, L (1969), p.551. 
29 JOHNSEN, AR (1978), p.323. 
30 Ibid (p.323). 
31 CAPRON (1984), pp.647, 652. 
32 SABATINO, CP (1994), p.1238. 
33 WINSLADE, WJ (1977). 






was drafted with the landmark case of Karen Quinlan in mind. That case was decided on an 
appeal by the New Jersey Supreme Court in 1976. 
Case law 1: main facts and decision 
Karen Quinlan was a twenty-one year old woman who became comatose after 
consuming alcohol along with barbiturate drugs while on a crash diet. Karen 
suffered severe brain damage and was diagnosed as being in a severe form of 
coma, called persistent vegetative state. She had laid in a hospital bed since 
April 1975 without any prospect of regaining consciousness, completely 
dependent of a ventilator.35,36 Karen’s father requested that the doctor 
disconnect the life-sustaining equipment to allow the daughter to die naturally. 
The doctor refused the request on the grounds that he could be accused of 
murder. Then, Karen’s father sought judicial approval to act as her legal 
guardian and to have the ventilator removed. The trial court did not allow the 
withdrawal of the ventilator. In spite of all the controversy around the case, in 
the appeal, the New Jersey Supreme Court ruled unanimously in favour of the 
Quinlans. The trial court granted the petition of Karen’s father, based on the 
constitutional right to privacy. The court however required that a responsible 
physician first determine that Karen would never recover from her persistent 
vegetative state. Notions of murder or improper interference with medical 
judgment were rejected by the trial court.37 
As an aftermath of the Quinlan case, the living will was formally recognized as an important 
means of conveying the wishes of a patient while still competent. At that time, many doctors 
still regarded pulling the plug as an act similar to euthanasia, strictly forbidden by the law and 
by the medical ethical code. The withdrawing or terminating ventilation of unconscious patients 
was for the first time debated, setting the stage for the advance care model that we know today. 
Historically, there were also several other important cases that addressed issues regarding the 
maintenance of life by artificial means. Quinlan’s case was one of the most significant38, as its 
result gave theoretical support to living will legal statutes. 
                                                          
35 PENCE, GE (2008), pp.23-28. 
36 POLAND, SC (1997), p.4. 
37 ROSNER, R (2003), p.317. 






Other jurisdictions quickly followed California’s lead in adopting living will statutes: Arkansas, 
North Carolina, New Mexico, Texas, Nevada, Idaho and Oregon39. In North Carolina, The Right 
to Natural Death Act was adopted in 1977. Appendix 2 develops the requirements and 
formalities that should be followed to prepare a valid advance directive pursuant to the updated 
North Carolina General Statutes40.  
Validity requirements and formalities41 42 43, ,  
 it must be made by a person with the necessary decisional 
competence and free from undue influence of others; 
 it must be in writing, signed, witnessed and notarized; 
 it must be currently in effect and not have been revoked; 
 it must be applicable to the current circumstances, identifying the 
medical treatment proposed or refused. 
By 1992, forty-five states and the District of Columbia had adopted statutes to facilitate a 
natural death in various formats, but with some relevant common elements44. However, 
limitations of the living will became apparent. States began to recognize that having a surrogate 
decision-maker might be more effective than just having someone write out a directives that 
turned out to be excessively broad, too vague, or have limited application45. A more effective 
approach was thought to be the naming of a proxy, trusted by the patient, who could ensure that 
the patient’s wishes were honoured. A proxy could give the necessary guidance to help 
physicians determine the wishes of the patient. The idea was to name a person who would speak 
for the patient.  
As such, by the mid-1980s, legislators and policy makers began to adapt an already existing 
legal document: the power of attorney. While some concerns arose around the use of the 
                                                          
39 HORAN, DJ AND MARZEN, TJ (1978). 
40 At: https://www.ncleg.net/gascripts/statutes/Statutes.asp. 
41 Although requirements vary from state to state, generally speaking, to determine if an advance directive is legally 
valid, these criteria should be met. This list is based on the North Carolina legislation. 
42 A list of requirements of all the states is at: http://estate.findlaw.com/living-will/living-wills-state-laws.html.  
43 HUNT, G et al. (2002). 
44 STEINLE, SJ (1992), p.439. 






traditional power of attorney in the medical context, the advantage of using these documents as 
a health care decision tool over the living will became clear. California once again was the first 
to enact the law: The 1983 Durable Power of Attorney for Health Care. By 1997, all US states 
had a version of health care power of attorney legislation46.  
Nevertheless, because of the complexity of the advance directives as legal documents, which 
constrained their use, states started to enact combined statutes merging the living will and the 
health care power of attorney into a single directive (e.g., the New Jersey standard form first 
dated from 1991)47. Over the years, statutes evolved so that, nowadays, many authorize default 
surrogate decision-makers for patients without decisional capacity in the absence of an advance 
directive. Organ donation directions are also options included in the legislation48, as it is 
prescribed in the North Carolina General Statutes. 
Although states intended to facilitate advance directives, laws varied from state to state, which 
led to the effort to draft uniform laws. These laws aimed to promote uniformity across the states 
in an area where consistency was needed49. Besides, with the movement of people between 
states, there was a risk that a person who had executed a directive in one state might become 
seriously ill/injured in another state, which was reluctant to honour the previously stated 
wishes50. Even if state courts concluded that there was a right to refuse life-prolonging 
treatment, there were differences in terms of principles and legal approach in some cases 
involving patients without decision-making capacity.  
Initially, the National Conference of Commissioners on Uniform State Laws approved the 1985 
Uniform Rights of the Terminally Ill Act (URTIA). While this uniform act aimed at simplifying 
end-of-life decision-making, it did not gain acceptance. The main reason for its failure was that 
it was too narrow in its scope. It did not cover important issues, like treatment of patients who 
had not signed the declaration directing physicians to withdraw or withhold life-sustaining 
treatment. It also failed to address problems related to minors51. In spite of the drafting of the 
                                                          
46 Ibid (pp.214-215). 
47 SABATINO, CP (2010), p.216. 
48 Ibid. 
49 PUTMAN, WH (2010), p.262. 
50 CHAPMAN, M (1989), p.346. 






URTIA, the US continued to have a system of fragmented legislation, often in sufficiently 
comprehensive and inconsistent among states. 
Consequently, in a second effort to achieve uniformity, in 1993 the Uniform Law 
Commissioners approved the Uniform Health Care Decisions Act (UHCDA) and replaced 
URTIA. The UHCDA consolidated several types of state laws dealing with decisions related to 
adult health care, end-of-life care and health care powers of attorney. This Act was designed to 
create a single document that would combine the existing living will and the health care power 
of attorney, which to that point were addressed in separate laws in most states. The UHCDA 
was intended to be a more comprehensive and “flexible combined advance directive and default 
surrogate law”52. This statute was described in contrast to URTIA as “strives[ing] to pave a 
health care decision-making superhighway”53. It is considered to be an important tool against 
the confusion, complexity and fragmentation of state health care decision legislation.  
The UHCDA is mainly characterized by the simplicity of its rules and its recognition of almost 
any type of written or oral statement as an advance directive, including unwitnessed 
documents.54 It provides an optional form for executing a health care power of attorney, which 
permits authorization of anatomical gifts. It further recognizes default surrogates in the absence 
of a directive. It affirms the legitimacy of close family decision-making and provides a ranking 
list of authorized surrogates.55 
At the same time as uniform laws were being devised,56 courts were deciding important cases 
linked with the public debate over honouring an individual’s wishes. The decision of the US 
Supreme Court in Cruzan v. Director, Missouri Department of Health, 497 US 261, in 1990, 
played an important role on the evolution of legislation regarding advance directives57. 
 
 
                                                          
52 SABATINO, CP (2010), p.216. 
53 SABATINO, CP (1994), p.1239-1240. 
54 SABATINO, CP (2010), p.217 
55 SABATINO, CP (1994). 
56 Studies performed later found that there were still variations across the US (GUNTER-HUNT, G et al. (2002)). 






Case law 2: main facts and decision 
Nancy Cruzan was twenty-six years old in 1983 when she was rendered comatose 
after a car accident, never regaining consciousness. She was in a persistent 
vegetative state and was only kept alive by a feeding tube. She did not need 
artificial mechanical respiration.58 Confronted with their daughter’s medical 
situation, her parents started a legal battle to have the feeding tube removed. The 
case proceeded its way through the courts up to the US Supreme Court. While the 
Supreme Court did agree with the principal that there is a right for a competent 
person to refuse or stop life-preserving medical treatment, including artificial 
nutrition, the court also ruled that individual states could set their own standards 
for evidence showing what the formerly competent patient would have wanted 
done in terms of life-sustaining medical treatment. Hence, technically the state of 
Missouri won the case, because their clear and convincing evidence standard was 
upheld.59 After the decision, the Cruzans went back to the Missouri courts and 
offered additional evidence that met the clear and convincing evidence standard. 
Only at that point, did the court approve withdrawal of Nancy’s feeding tube, 
allowing her wishes to prevail. She died a few days later on December 26, 1990.60 
The Cruzan case was important, because for the first time the US Supreme Court recognized 
the constitutional right of a competent American to refuse unwanted medical treatment. It 
concluded that removing a feeding tube is indistinguishable from removing a ventilator. 
However, the Supreme Court allowed states to set a rigorous standard - requiring clear and 
convincing evidence - for permitting surrogate decision-makers to withdraw life-sustaining 
treatment when the patient is incompetent.61 
As a follow-up to this case, at the federal level, in 1991, The Patient Self-Determination Act of 
1990 came into force. Under the Federal Statute, hospitals or extended care facilities, like 
nursing facilities, home health agencies, hospices, and Health Maintenance Organizations 
(HMOs), that receive Medicare or Medicaid reimbursement, are required to give patients at the 
time of their admission, written information on state’s laws regarding their rights to make 
decisions about medical care, such as the right to accept or refuse medical or surgical treatment, 
                                                          
58 POLAND, SC (1997), p.5. 
59 Most states do not have such a high evidentiary standard. 
60 GRANT, ER (2015). 






including the execution of advance directives. Notwithstanding its minimal role in this 
legislative evolution, the Congress hoped to reinforce individuals’ constitutional right to 
determine their final health care (i.e., right to self-determination), and to increase public 
awareness about planning for future health care decisions. 
Recently, the case of Terri Schiavo, which raised a factual question about whether the patient 
had expressed the desire to remove life support when in a persistent vegetative state, led to a 
highly political debate in the US. 
Case law 3: main facts and decision 
Terri Schiavo was an anorexic twenty-seven year women who fell into a 
persistent vegetative state after suffering a cardiac arrest in 1990. After a 
number of years, Terri’s husband, appointed as her legal guardian, wanted to 
remove her feeding tube, arguing that she would not have wanted her life 
artificially prolonged. In contrast, her parents opposed their son-in-law’s 
decision and never accepted the diagnosis of persistent vegetative state, even 
with physicians expressing the opinion that there was no hope of Terri’s 
rehabilitation.62 Schiavo’s parents and husband initiated a long litigated battle 
that involved several state and federal courts. All ruled in favour of the 
husband’s petitions. In spite of those rulings, in 2003 the Florida legislature 
passed a controversial bill - Terri’s Law - that gave the Governor the authority 
to have the feeding tube reinserted (when a court had ruled that it could be 
removed). This bill was later declared unconstitutional. After several years of 
legal struggle that reached non-judicial branches, in March 2005, the feeding 
tube was finally removed by court order, and Terri passed away thirteen days 
later.63 
Although this case did not raise any novel legal or ethical issues - because the right to remove 
feeding tube was already well established - it provided a lesson on how religious and political 
debates on sanctity of life can inject themselves into what would otherwise have been an 
uncomplicated case that raised no new legal issues. Terri’s story extended the legal debate about 
the end-of-life decisions beyond courts to the political arena, involving the Governor of Florida 
and Congress. It attracted religious conservatives who were pressing the right to life fight. The 
                                                          







Schiavo case illustrates that in spite of many efforts, there is still a lot of confusion and 
disagreement in the US about withdrawing life-sustaining treatment of incompetent patients. It 
shows what happens when there is no written directive to reveal what the incompetent person 
would have wanted, and family members are in conflict about end-of-life care. Ultimately, this 
case demonstrates the importance of communication and dialogue between clinicians and 
patients, including family members in solving ethical dilemmas.  
Even though there are more current debates on health care reforms, federalization of advance 
care law will not happen at substantive level. In the US system, end-of-life law is a matter 
reserved to the states only and it is not within the power of the federal government, unless there 
is a conflict with the Constitution. 
1.3 Advance Care Planning: a new paradigm  
Presently, Americans are already in a third generation era of advance directives. Recognizing 
the limitations of these directives, with low completion rates despite decades of existence, 
Advance Care Planning or ACP emerged as a new and alternative communication paradigm64 
that emerged more recently65. It consists of an ongoing, flexible and interactive process of 
communication between patient and physician on the patient’s preferences for end-of-life care. 
It goes beyond a mere execution of legal documents, although advance directives are a tool for 
making advance care planning66. An example of an ACP tool is the Physician or Medical 
Orders For Life-Sustaining Treatment (abbreviated as POLST or MOLST67), designed 
especially for seriously ill patients to have more control over their end-of-life care. 
The POLST or MOLST is a much more detailed document that can put the patient’s end-of-life 
wishes and preferences into a medical order. It is more situation specific than the traditional 
advance directive and it is created as a joint effort by the patient and physician. This tool 
requires interaction and communication between the patient or his or her surrogate and the 
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physician in charge about the patient’s end-of-life wishes that are integrated into the physician’s 
orders.  
In contrast to the traditional directives, which can be completed by all competent and healthy 
adults, POLST is a tool for seriously ill patients of any age, who have life expectancy of less 
than one year, to have more control over their end-of-life decisions. POLST68 give specific 
actionable orders for current treatment, whereas advance directives give only general 
instructions for future treatment. Moreover, POLST is designed to direct care both in home and 
outpatient settings and to facilitate transfers within hospitals. These orders are kept by the 
patients and are portable, meaning that they travel with the patients throughout different health 
facilities69.  
A number of studies have evidenced the positive outcomes and effectiveness of ACP70. Some 
of the benefits found are less aggressive medical care71 and better quality of life near death72, 
with higher satisfaction and a reduction of psychological distress of both patients and families73. 
Evidence suggests as well that POLST are quite useful for patients who have progressive 
chronic illness and it has been shown to reduce the likelihood of receiving unwanted medical 
intervention in nursing home patients74. 
Oregon was the first state to develop the POLST in the early 90s, with more states authorizing 
it later on. It is now widely recognized among health care professionals. This new paradigm 
was considered as “a sea change in advance care planning policy standardizing provider’s 
communications to prescribe a plan of care in a highly visible, portable way, rather than solely 
on standardizing patient’s’ communications”75. It represents an important step toward achieving 
the best outcomes for patients and their families in terms of end-of-life care76. 
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69 DETERING, K AND SILVEIRA, MJ (2017). 
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In 2008, Congress added the end-of-life planning77 to the Welcome to Medicare exam. As part 
of this exam, the medical provider will also offer to talk to the beneficiary about advance 
directives and end-of-life planning. Moreover, from 2016, there is a Medicare78 billing code for 
advance planning conversations.79 These reforms facilitate a process of discussion and 
communication between an individual and the health care provider.  
Advance Directives developments in a snapshot 
 
1914 - Cardozo decision affirming patient autonomy and self-determination 
1969 - The living will is first mentioned in the US by the Lawyer Luis Kutner 
1976 - Karen Ann Quinlan Supreme Court decision 
1977 - The California Natural Death Act entered into effect  
1983 - California passed the first Durable Power of Attorney for Health Care 
Statute 
1990 - Nancy Cruzan Supreme Court’s ruling 
1990 - The Patient Self-Determination Act was enacted (as an amendment to the 
Omnibus Budget Reconciliation Act of 1990) 
1991 - New Jersey enacted the first combined statute 
1995 - Physician Orders for Life-Sustaining Treatment (POLST) form, an 
important ACP tool, was first released for use in Oregon80  
2003 - Terri’s Law was passed giving the Florida’s Governor the authority to 
order to reinstatement of Terri’s nutrition and hydration 
2016 - Began the Center for Medicare and Medicaid Services’ reimbursement 
of physicians for advance care planning conversations 
 
                                                          
77 42 US Code § 1395(x)vv(3). 
78 Government-funded social insurance for the elderly or disabled. 
79 At: https://www.cms.gov/Outreach-and-Education/Medicare-Learning-Network-
MLN/MLNProducts/Downloads/AdvanceCarePlanningText-Only.PDF 






CHAPTER TWO  
COMPARATIVE ANALYSIS  
2.1 Portuguese framework: state of affairs in advance medical care  
Unlike in the US, in European countries the public debate about the role of advance directives 
in medical practice was initiated only recently. Until 2005, the concept of advance directives 
was practically unknown in Portugal. Specific legislation on this matter was enacted much later. 
Throughout the years, across Europe, countries have adopted different approaches regarding 
this subject depending on their own backgrounds. While countries like the UK, Austria, Spain, 
Hungary, Belgium, The Netherlands and Finland were pioneers in passing specific laws to 
address advance directives, Portugal had no specific legislation on the matter until 201281.  
In 200182, Portugal ratified the Europe’s Convention of Human Rights and Biomedicine dated 
from 1997, known as Oviedo Convention, with its Article 9, being an important starting point 
in the introduction of the subject of advance directives in the country. This provision provides 
that, “The previously expressed wishes relating to a medical intervention by a patient who is 
not, at the time of the intervention, in a state to express his or her wishes shall be taken into 
account.”83.  
Although the Oviedo Convention was part of Portuguese domestic legislation, advance 
directives remained without a specific legal status for a long time. In reality, “There [was] 
nothing to prevent a person making what is called a living will”84. Furthermore, “appointing a 
proxy to take care of health issues could, by analogy, be framed within the civil discipline of 
the institution of power of attorney”85. Nevertheless, the validity and efficacy of such 
documents was unclear until the enactment of Law no.25/2012, from July 16, called the Living 
Will Law86.  
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The traditional view considered a power of attorney in life and death matters highly doubtful. 
Some doctrine expressly denied the possibility of delegation of end-of-life decisions87. Even 
for scholars that considered this delegation possible88, as well as having a living will for end-
of-life care, they did not view these documents as binding in absolute terms89. The documents 
were seen as containing the strongest indication of the presumed will of the declarant – “mais 
forte indício da vontade presumida”90 – or by having at least an advisory value – “mero valor 
indiciário”91. In addition, if doubts persisted, the decisions of physicians should always be made 
based on the principle in dubio pro vita, pro salute, pro persona92. Thus, specific legislation 
was necessary to confer binding power to the directives, or otherwise physicians could reject 
their content and not apply them93.  
While a specific law was not enacted, these directives were covered indirectly by other 
legislation94.  In the European Charter of Fundamental Rights from 2000, Article 3, paragraph 
2 (“Right to the integrity of the person”) establishes that “In the fields of medicine and biology, 
the following must be respected (…): - the free and informed consent of the person concerned, 
according to the procedures laid down by law.”95. It is broadly accepted that the right to 
informed consent of patients includes the possibility to refuse medical treatment96. 
Moreover, “there is a constitutional framework97 that takes autonomy seriously (…). Second 
the Convention on Human Rights and Biomedicine came into force on December 2001; third, 
the appeal to general institutes of civil law98 seem to mitigate the absence of special rules; 
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89The National Council of Ethics of Life Sciences in 2005 issued the Opinion 46/CNECV/05, in respect to the 
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91 ANDRADE, MC (2004), p.457.  
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fourth, the Penal Code99 should be taken into account as far as respect for the will is 
concerned”100.    
Additionally, Principle XIV of Law no.48/90, of August 24, which establishes the basic 
principles for health care in Portugal, states that every patient has the right to consent to or 
refuse health care and to be informed about his or her situation, alternative treatments and 
prognosis. The duty of informed consent was also prescribed in Article 44 of the Medical 
Deontology Code101. Article 46, number 2 expressly states that if there is a written 
statement/directive from the patient expressing his or her wishes about medical treatment, it 
should be taken into consideration by the health care provider.  
The implementation of the law on advance directives in 2012 was not without controversy. 
Opinions diverged widely. Even among health care providers, this subject was controversial102. 
Some voices expressly rejected it and claimed that the living will would be a sort of Trojan 
horse aimed at the legalization of assisted suicide/euthanasia103. Others recognized the need of 
having specific and adequate legislation to regulate these directives104 based on the principle of 
respect for autonomy105.  
Portuguese were not indifferent to overseas cases, like that of Terri Schiavo, involving life-
extending technologies and surrogate decision-making of patients in a persistent vegetative 
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Case law 4: main facts and decision  
Eluana Englaro was a twenty-one year old girl who was left in a persistent 
vegetative state after a car crash in 1992 and only in July 2008, the Italian Court 
of Appeal had given authorization for artificial life-support to be withdrawn. 
However, an emergency decree was enacted stating that assisted feeding and 
hydration must not be withdrawn for any patient in a state funded health facility, 
reversing the earlier court ruling.106 This case gave rise to substantial political 
turmoil and public debate with the involvement of the courts, including the 
European Court of Human Rights, the government and even the Vatican.107 
What would have happened if Eluana was Portuguese? It was controversial. In 2009, some 
argued that in the case of Eluana, who had been in a persistent vegetative state for a long time, 
it was legitimate to suspend active treatments (i.e. antibiotics), because medicine has to be 
useful/beneficial. “If medicine is futile, is contrary to its basic principles.”108. Likewise, others 
opined that withdrawal of artificial feeding in this case corresponded to the suspension of what 
is considered a disproportionate means of treatment. “From a human point of view, being in 
this condition is worse than being dead.”109. Some, however, would have never suspended the 
feeding/hydration of a patient in this situation110 or argued that food is a way of sustaining life, 
not a mere therapy, and thus cannot be withdrawn111.  
This case played a crucial role in Portugal, because it showed that physicians/specialists did not 
agree on how to solve this type of case. It brought into debate the idea that medicine does not 
have to keep people alive at all costs, and that questions of discontinuing feeding/hydration 
should be analyzed on a case-by-case basis. A doctor “does not have to feed and hydrate a 
patient at any cost if that means suffering for the person”112, compromising the patient’s quality 
of life. Eventually, it showed the importance of a document with the patient’s previously stated 
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wishes – in the form of a living will – which could facilitate such decisions by medical 
providers113.  
The debate around these directives is connected with persistent vegetative state cases, terminal 
illnesses and therapeutic futility (i.e., permanent incapacity)114. However, the debate also arose 
in connection with refusals of blood transfusions by Jehovah’s witnesses during surgical 
interventions (i.e., temporary incapacity)115. The National Council of Ethics of Life Sciences 
had issued in 2005 two Opinions, 45/CNECV/05 and 46/CNECV/05, covering both situations. 
The living will was first mentioned, but only briefly, in Opinion 11/CNECV/95 issued in 
relation to the ethical aspects of health care regarding the end-of-life116. 
In fact, it was only in May 2006 that the Portuguese Association of Bioethics initiated the debate 
specifically about advance directives through the Advice P/05/APB/06117. It covered different 
types of directives, their validity, limits and requirements, in line with the Recommendation 
1418 (1999) on the Protection of the human rights and dignity of the terminally ill and the dying 
of the Parliamentary Assembly of Council of Europe118. One year later, the Association 
presented legislative Proposal P/06/APB/06, to specifically regulate advance directives and to 
create a National Registry. In 2009, another legislative Proposal, P/16/APB/09, was issued with 
the same goals119. In 2008, the Association issued Guidelines P/11/APB/08 on the withdrawing 
and withholding of treatments of terminal ill patients. In December of 2010, the National 
Council of Ethics for the Life Sciences had issued a favorable Advice 59/CNECV/2010 on 
these directives, providing several recommendations, including on providing of information 
about the possibility of registering these directives. 
Subsequently, between 2009 and 2011, many legislative proposals were presented and 
discussed in the Parliament and several hearings were conducted with experts in the field. After 
long debates and numerous projects of law - 788/X, 413/XI/2ª, 414/XI, 428/XI, 429/XI/2ª and 
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21/XII/1ª, 62/XII/1ª, 63/XII/1ª, 64/XII/ª - presented by different wings of the Portuguese 
Parliament120, the Living Will Law was enacted in 2012121,122,123.  
The Living Will Law has a triple object: i) to establish the legal regime of advance directives; 
ii) to regulate the appointment of the health care proxy; and, iii) to create the Living Will 
National Registry (RENTEV)124. According to the Law, any citizen at least eighteen years old 
and duly capable may declare in advance, and in a clear, conscious and informed manner, his 
or her wishes regarding medical care, by preparing an advance directive. These directives may 
take the form of a living will and a health care power of attorney. Appendix 3 summarizes the 
main components of Law no.25/2012. Needless to say, this Statute pays tribute to patients’ self-
determination.  
2.2 My Macanese experience  
Advance directives is a relatively new concept in Macau. To date, there is no law in the Region 
that specifically addresses the subject, due mainly to cultural reasons and lack of exposure to 
the matter. The majority are hesitant in deciding about future medical care, preferring to leave 
it in God’s hands. Moreover, family views weight heavily on end-of-life issues. Decisions are 
mainly made collectively,125 meaning that the concept of autonomy on which advance directives 
is based might not be important in this culture. 
There is no local case law on the matter and there is not a project of law even in an embryonic 
stage being discussed by legislators. Moreover, in Mainland China, until now no specific law 
has been issued regarding end-of-law decision-making126. In Hong Kong, next to Macau, no 
law has been enacted so far, though in December 2009, the government published a 
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Consultation Paper on the Introduction of Advance Directives in the Region127. Macau is a 
Special Region in China, characterized by its bipolarity. It has strong influences from the 
Western legal tradition, through Portugal, but with an increasing Chinese influence, mainly 
after 1999128.  
Given the Portuguese heritage in Macau legal system129, there are some provisions of local law 
that address advance directives. Decree-Law no.111/99/M, of December 13, establishes the 
legal framework on the protection of human rights and human dignity in the face of biology 
and medicine applications. This Law was issued during Portuguese administration and it is 
based on the Oviedo Convention. Article 8, number 2 (“Urgent situations”) establishes that “It 
is taken into account the will previously expressed in respect to a health care intervention, by a 
person who, at the time of the intervention, is not in a position to express his or her will.”. 
However, the expression “it is taken into account” does not mean that the doctor must 
compulsorily follow the previous expressed wishes of the patient. 
Moreover, as per Article 30 of the Basic Law, “The human dignity of Macau residents shall be 
inviolable.”130. The Macanese Civil Code (and its Article 67) is similar to the one in force in 
Portugal. As for the Criminal Code, it establishes in Article 150 (“Arbitrary medical-surgical 
procedure”) that a physician who acts without the patient’s consent, either expressed or 
presumed, commits the crime of arbitrary medical intervention. This crime aims to protect the 
person’s self-determination in matters related to medical treatment. The duty to inform is 
prescribed in its Article 151, and presumed consent is in Article 38. This duty is also present in 
the legal regimes that regulate the physicians’ and pharmacists’ careers in the Region.  
More recently, there were some voices from the medical community that started calling for 
awareness about the importance of these directives, namely in respect to the elderly. In Macau, 
the aging of the population is a public health concern. Some doctors have voiced the need for 
advance directives in the Region, as have experts in the field, including scholars, legal advisors 
and lawmakers131. As was the case in Portugal, in Macau, there is nothing in the law that 
prevents the execution of these directives, but they are not legally binding. Presently, the law 
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provides a sort of remedy to the current lack of guidance in the area of death and dying. These 
documents merely provide an indication of the patient’s preferences.132 
If a situation like the Schiavo case happened in Macau, with a patient maintained on life-
sustaining treatments for a long period, unable to provide the required consent, the doctor must 
apply for presumed consent as per Article 150, number 2 of the Criminal Code. Unless 
trustworthy information is given by a family member or even by an advance directive133 about 
the patient’s health care wishes, “the doctor must treat the patient as if he has given the 
necessary consent, since this is the most reliable option from an objective perspective”134. 
Physicians would also tend to act in favor of life (favor vitae) of the patients, in order to avoid 
any criminal and civil liability. 
Macau is predominantly made up of a Chinese population that practices Chinese cultural 
traditions. Death is a very sensitive issue135. “Because of Chinese people’s culturally strong 
habit of denying death, health care professionals often find it difficult to discuss end-of-life 
care”136. Additionally, “Chinese tend to ask their doctors to try to prolong life as long as 
possible.”137.  In Hong Kong, where Western and Chinese medicine also coexist, a study 
showed that: “traditional Chinese societies place greater emphasis on such community values 
as harmony, responsibility, and respect for parents and ancestors. Specific areas of cross-
cultural conflict include: the role of the patient and family in medical decision-making; the 
disclosure of unfavorable medical information to critically ill patients; the discussion of 
advance directives or code status with patients; and the withholding or withdrawal of life 
support.”138. In Chinese culture, family relationships assume primary relevance and relatives 
play a decisive role in a patient’s medical treatment plan.139 In Macanese health care facilities, 
it is common practice for physicians to listen to the patient’s family members. 
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Notwithstanding potential difficulties of implementation of advance directives in the Region, 
some scholars assert that these instruments should be specifically legislated to grant them 
binding force140. 
2.3 Diverse cultural mind-sets and demands among world regions 
Advance directives have been in place for several years in Western countries, but are relatively 
new for Asian people141, mainly Chinese. There are factors beyond access to information or 
lack of awareness that may influence the decision not to complete an advance directive. Cultural 
and religious factors contribute greatly to the development of these directives being slower and 








Are more organized, pragmatic and less sensitive to some issues, one being 
end-of-life planning. Usually, are less influenced by certain religious beliefs 
and philosophies about life and death. Consequently, are keener to engage in 
discussions about health care planning. In general, Americans are also more 
knowledgeable about advance directives, their content and goals, than 
Portuguese and Chinese/Macanese. When compared with Portuguese and 
Chinese/Macanese, Americans are more likely to have executed some sort of 
directive or at least having talked about their wishes for end-of-life medical 
care with a doctor. If in America completion rates of advance directives are 
relatively low (approximately 35%), in Portugal the execution of these 
documents is still rare. 
Portuguese culture is strongly rooted in the Catholic religion. The Catholic Church proclaims 
that human life is sacred. Prominent Catholic views about the sacredness of life might be a 
constraint for completion of advance directives. This is true even though there are many people 
who described themselves as non-religious or non-practicing Catholics and the Catholic Church 
has already issued a favorable opinion to the Living Will Law142. Moreover, the typical 
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Portuguese does not like to talk about death and dying143. It is depressing to talk about this 
topic, some say. Unwillingness to talk about death may be another obstacle for execution of 
these directives. Nevertheless, if denial of death is a key part of the problem, general lack of 
awareness and inattention to the issue of advance care planning is also important. Lay people 
do not even know what these documents are, what is contained in them, and have not ever 
thought about the matter. They have never talked about the subject with their primary care 
physician.  
While an estimated 35% of adults in the US have done an advance directive144, in Portugal 
completion rates are approximately 1%.  A study performed in 2013 by the Catholic University 
in partnership with the Palliative Care Association, found that 78% of Portuguese adults still 
did not know what a living will is145. This study also found that only 50,4% Portuguese knew 
what to do and where to go in order to execute an advance directive, and only 1,4%146 actually 
had formally executed one.   
Considering the above, in July 2015 there were only 1468 living wills147 executed and registered 
at the Portuguese National Registry. According to official records published at the National 
Health Service website, in May 2017, this number went up to 12.019148. In February 2018, the 
total number of registered living wills was 18.809.  
Appendix 4 shows updated official data from the Health National Service.  
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Continue not knowing what a living will is. In spite of having gained legal 
status, the concept of advance directives is practically unknown. Although the 
Catholic Church has expressed a favorable opinion149 of the living will and 
Law no.25/2012, Portuguese are mainly Catholicism embodied. For Catholics, 
human life is a supreme value that should be preserved. Death is a subject 
that is generally avoided. An evident reason is that death is feared. This means 
that Portuguese are more reluctant to talk about death and what to do if 
diagnosed in the future with a terminal illness. Moreover, while most people 
procrastinate frequently, namely in respect to complex/sensitive issues, others 
often think that this what if scenarios will not happen to me.   
Macau is a cross-cultural zone influenced by Western culture for historical reasons because of 
Portugal. However, the reality is that Macau is a Special Region part of China, hence, deeply 
rooted in Chinese traditions and values. Chinese culture, based mainly on Confucianism150, is 
determinative in core issues like end-of-life care. For Confucians, death is something unwanted. 
Confucians hold a high moral value to life. If an individual does not struggle with effort to live 
and gives up life easily, he is seen morally as a defeated person. Thus, for Chinese, death is a 
very sensitive and a sacrilegious issue. For example, Chinese often do not have a fourth floor 
in their residential buildings and avoid using number four in their cars registration plates, as in 
Chinese number four (四, pinyin: sì) sounds similar to the word death (死, pinyin: sǐ).151 
Confucian thinking and culture also contributed to the creation of a system of Chinese 
traditional medical ethics which “contains concepts such as the need: to attach great importance 
to the value of life; to do one’s best to rescue the dying and to heal the wounded; to show 
concern to those who suffer from diseases;”152.  
Based on these religious beliefs, personal autonomy is less valued than family relationships. 
Obligations that are inherent and constitutive of key relationships in China take precedence 
over certain individual rights. In fact, family members play a decisive role in a patient’s health 
care plan. Reflecting Confucian teaching, a decision about end-of-life medical care without 
consulting the family, especially the oldest son, it is unthinkable. Confucian philosophy elevates 
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family values and respect for the oldest person. Filial piety is a virtue of respect for parents. 
Dying/death is perceived a family matter instead of a personal issue.153 As such, the 
implementation of advance directives without direct involvement of the family members will 
be impossible. In a nutshell, death is taboo, life is attached to great moral value, and relatives 












Chinese, with Confucian traditions, see death as taboo and something 
undesired. Talking about dying is considered to bring bad luck. In all cultures, 
American, Portuguese and Macanese/Chinese, people tend to involve their 
family members in these matters, relying mainly in their spouses and/or 
parents as decision-makers. Nevertheless, in Chinese culture, end-of-life 
decisions is seen primarily as a family responsibility. In Macau, Western 
culture is definitely present, but Chinese traditions say that they are more 
likely to prefer a collective/family-centered decision-making approach. 
Cultural and racial differences and ethnic backgrounds have a powerful effect on advance 
directives completion and implementation. People’s preferences, beliefs and values shaped by 
their own culture greatly influence end-of-life care discussions. Religion also affect how 
individuals view life, death and end-of-life health care. Based on my experience of having lived 
in three different Continents, complemented by an informal survey conducted for the purposes 
of this research, it was possible to reach some key findings detailed in Appendix 5. 
Certainly, this analysis should be viewed with caution and consider the existence of overlap in 
attitudes among distinct ethnic and racial groups over the world in order not to stereotype 
patients. Moreover, there are other important factors to consider with respect to advance 
directives completion: level of education/higher income, access to information, geographical 
location (urban v. rural), gender, (older) age, marital status154, exposure/presence of a chronic 
progressive condition or life threatening diseases155. 
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CHAPTER THREE  
ECONOMICS OF DYING  
3.1  Effectiveness of Advance Directives and ACP in reducing health care costs 
All over the world, health care systems are facing dramatic increases in expenditures, in great 
part because of medical technology innovations that allowed an extension of complex surgical 
procedures, changing the treatment of illness, and improving outcomes for sicker and older 
patients156. Our society is aging and with that, chronic diseases will rise globally. As the over-
sixty-five age group keeps growing, so will the cost of health care. Medical technology157 is 
considered one of the most important factors in the growth of health care costs158. 
In the US, a country that compared with other developed nations has a more expensive health 
care system, health care expenditures as a share of gross domestic product (GDP) have risen 
from 5% in 1960 to 18.3% in 2017159.  As for Portugal, in 2013, public and private health 
expenditures as a share of GDP was 9.0%, compared with the Organization for Economic 
Cooperation and Development (OECD) average of 8.9%160. Portugal had the 14th highest level 
of spending as a share of GDP in the thirty-four OECD countries during that year. In terms of 
public expenditures, according to more recent data from Eurostat’s database, the general 
government total expenditure on health in 2015 was 6.2% of the Portuguese GDP161. Thus, a 
large share of health care spending is financed by the public sector162. In Macau, as of the last 
data available in 2013, total health care expenditure was estimated at 1.5% of GDP, which is 
lower when compared with near countries/regions, like Mainland China163 and Hong Kong164. 
                                                          
156 ANTUNES, JB (2010), pp.161,189. 
157 DASTA, JF et al. (2005). 
158 NEWHOUSE, J (1992). 
159 At: https://www.statista.com/statistics/184968/us-health-expenditure-as-percent-of-gdp-since-1960/. 
160 At: https://www.oecd.org/portugal/Country-Note-PORTUGAL-OECD-Health-Statistics-2015.pdf. 
161 http://ec.europa.eu/eurostat/web/products-eurostat-news/-/DDN-20170825-1. 
162 BARROS, PP et al. (2007), p.127. 









Data and charts are available in Appendix 6. 
In addition, health care costs increase significantly in the last year of life165. In 1993, the 
exponential rise in Medicare expenditures in the last year of life was already prominent in the 
US, with payments per patient-year increasing almost four times166. Moreover, health care costs 
at end of life represent a high proportion of overall health care, with the “percentage of Medicare 
payments attributable to patients in their last year of life [at a rate of] 25.1% in 2006”167. 
Recently, another study found that approximately half of older Americans have high spending 
on health care a year before they died, mainly because of the care received for various chronic 
medical conditions, including visits to the doctor and regular hospital stays over that year.168 
With the rising trend in per capita health care expenditure, especially at the end of life, there 
are strong economic interests in keeping such expenditure at a relatively stable growth rate. 
Advance directives, seen as a primary tool to promote patient autonomy, have also been 
discussed as a means to save and control medical costs at end of life169. How many billions in 
annual health care expenses could be saved if all adults had an advance directive formally 
executed? Terminal diseases require costly aggressive medical intervention170. Physicians often 
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have to struggle with limited and quite expensive medical resources, namely in relation to life-
sustaining treatments.  
At first glance, it might not be absurd to link the use of advance directives with a decrease in 
health care costs, especially at end of life. According to a study, patients who had executed 
living wills tend to prefer limited or comfort care (92.7% and 96.2%, respectively) than all care 
possible (1.9%)171. If we think that directives are directly linked with fewer life-sustaining 
interventions, we would expect that less medical care consequently means lower medical 
costs172. Nevertheless, several other studies have found almost no effect of these directives on 
a number of outcomes from different features including, for instance, length of hospital stay, 
level of pain and on health care costs too.173 In fact, there are many studies that reached the 
same conclusion: the use of advance directives do not affect health care expenditures.  
In 1994, a study showed that cost savings for reducing the use of aggressive life-sustaining 
treatments for dying patients “is at most 3.3 percent of total national health care 
expenditures.”174, which is not substantial. The SUPPORT study, a randomized controlled trial 
reported in 1995 with over 4804 US patients with an average age of 65, measured patient’s 
hospital charges during hospital stays. It concluded that the directives did not reduce use of 
hospital resources and had no overall impact on costs175. Moreover, a 1997 study on resource 
utilization concluded that the increasing use of advance directives was not linked with a 
reduction in hospital resource utilization176.  
Hence, promoting advance directives with the aim of reducing health care costs is not likely to 
be successful, and even if there are some savings, they may be overstated177. The fact that the 
directives are not widely used also contributes to their lack of impact in terms of resource use 
and costs of care at end-of-life. Furthermore, the promotion and implementation of programs 
of advance directives entail substantial costs as well178.  Although most studies have failed to 
give evidence that directives contribute to decreased resource use and health cost control, a 
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recent study showed that the impact of these directives is dependent on the region where the 
patient receives care. In fact, in regions where health care expenditures are already low, advance 
directives execution seem to have no impact on health care costs. In areas with high levels of 
end-of-life care spending, these directives “were associated with significantly lower levels of 
Medicare spending”179. 
However, what about advance care planning, the new concept that has emerged and gained 
importance recently? In fact, from early studies that revealed no impact at all of traditional 
advance directives on health care costs, recent studies show something slightly different in 
respect to a systematic implementation of a program for the use of advance directives, and to 
end-of-life conversations and counseling.  
In a randomized controlled trial from 2000180, it was reported that per patient health care costs 
were significantly lower in nursing homes with a systematic implementation of a program to 
increase the use of advance directives (i.e., an average difference of $1,749CAN; 33.4%). This 
study also revealed that in these nursing homes there were fewer hospitalizations per patient 
and a lower average number of days spent in hospital.  
An observational study reported in 2009 in hospital patients with advanced cancer measured 
the costs for hospital stays and hospice use in the final week of life. The study revealed that 
aggregate costs of treatment were 35.7% lower for patients that had communicated (by 
conversations) their end-of-life wishes with their doctor compared to those who had not.181. 
Another study reported in 2010 shown that end-of-life counseling, “can reduce costs by 
facilitating voluntary election of less intensive care” (i.e., a reduction of $1,913 USD (4.5%)182).  
Although all these studies do not refer expressly to advance care planning, all demonstrate, at 
least, the potential to reduce end-of-life health care costs through the lifelong communicating 
process between patient and physician. Naturally, it is necessary to perform more randomized 
studies on ACP to produce reliable evidence on its possible costs implications183. 
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In Portugal and Macau, which have a different public health financing system in place, local 
studies are important to assess if this apparent cost-effectiveness of ACP also applies. Portugal 
is quite a small country and Macau is a wealthy Special Region in China with lower levels of 
overall health care spending when compared with the US. Moreover, there are relevant cultural 
and social factors to consider in terms of end-of-life wishes, as demonstrated. 
3.2 Ethical implications of Advance Care Planning becoming a purely economic strategy 
If advance care planning is confirmed to have an impact on overall health care expenditures, 
with cost containment as one of its main and explicit goals, ethical concerns may be raised. 
There is a significant potential risk of an ethical conflict between the primary goal of advance 
care planning, which is the promotion of patient autonomy, and the goal of reducing health care 
costs.  
In the US, a country with a health system based primarily on fee-for-service payment, there are 
strong incentives for physicians and health care institutions to prescribe more treatments and 
choose expensive ones184. They will make more money if they provide more 
intensive/aggressive procedures. 185  Hence, it may be tempting to encourage patients to pursue 
treatments, even if it is not truly necessary for the benefit of the patient. The Medicare system 
has been strongly criticized for rewarding the tendency to pay for increasing health care costs 
and for diminishing returns in terms of life expectancy186.  
However, since January 2016, physicians are eligible to receive reimbursement from Medicare 
for providing advance care counseling. One of the problems in the US is that there was a 
financial disincentive for physicians to discuss end-of-life care, because physicians generally 
could not bill for it187. This measure raised concerns that directives would lead to the denial of 
necessary health care. In 2010, a similar provision was removed from the Affordable Care Act 
prior to passage, because it had raised an intense political debate. Opponents argued that it 
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would create death panels, i.e., commissions of officials that would make decisions that 
rationed health care and limited medical treatment188.  
In Portugal, which has universal health care coverage and a nearly free health care system 
offered by the National Health Service189, there may be an incentive to use advance care 
planning to pressure patients to choose less intensive and, thus, less costly treatments. The 
promotion of advance directives may be involved in urging patients to refuse or limit end-of-
life treatments in order to control overall health care expenditures. As discussed, ACP may have 
the potential to reduce expenditure if patients choose to limit costly life-sustaining treatments. 
The problem arises when pressure is placed on the patient to choose less expensive treatment 
than he or she truly desires and needs. If a patient choose between treatment A and B, or choses 
no treatment at all, by some sort of undue influence, the openness and sincerity of the 
communication process that characterizes advance care planning will be in danger, 
compromising its rationale. There may be ethical implications if these directives and ACP are 
used as a principal means to contain costs, constraining patients’ autonomy. 
Nowadays, these concerns are even more relevant, due to the shortage of health care resources. 
There is great social and economic pressure to save money on health care. Considering the 
current economic context, not only end-of-life sustaining interventions, but also palliative 
sedation and anti-pain therapy have a considerable weight in the nation’s health care budget.  
Rationing of care is unavoidable in any health care system, regardless of the economic situation. 
The problem is not rationing health care resources, but rather how best to ration, respecting our 
societal values.190 Rationing may be justified if carried out by ethical and equitable means, 
safeguarding the relationship of trust between patients and health care professionals. Every day 
physicians take decisions based on cost-effectiveness motivations. According to the Portuguese 
Medical Deontology Regulation191, physicians should seek the most effective and efficient 
management of existing resources (Article 4, number 4). Good medical practices (leges artis) 
determine that physicians should refrain from prescribing unnecessarily expensive 
examinations/treatments and from performing superfluous medical acts (Article 7, number 2). 
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It would be false not to admit that cost containment and medical resources allocation is currently 
on the minds of physicians and medical institutions.  
Advances in medical technology have enabled physicians to prolong life of patients to an extent 
not known before. Medical costs rose. Consequently, today there are new pressures to limit 
costly health care procedures. Hence, in addition to the traditional medical practice to seek what 
is best for the patient, currently a cost-benefit analysis is also present, even if implicitly, in each 
treatment and medication administrated by physicians. They need to allocate and use resources 
responsibly. 
At a time where a cost-effective care is encouraged, protections are much needed in order to 
advocate for ACP, which has important positive outcomes, but also to guarantee protection of 
patient autonomy, and not inappropriately leading to denial of care. Recommendation 1418 
(1999) of the Council of Europe expressly warns of the need to ensure that “no terminally ill or 
dying person is treated against his or her will while ensuring that he or she is neither influenced 
nor pressured by another person”; and it further states: “safeguards are to be envisaged to ensure 
that their wishes are not formed under economic pressure;”192.  
For the same reason, financial incentives for advance care counseling as implemented in the 
US193, are not advisable in Portugal. Any reimbursements to the physicians for time spent with 
patients discussing advance directives or to encourage talking about end-of-life care should be 
seen with caution. It may be linked to incentives to pursue less invasive and less expensive 
treatments, influencing decisions to avoid medical care with the risk of jeopardizing patient 
autonomy. Any decision about future wishes expressed in an advance directive has to be 
genuine and voluntary.  
A last note to conclude this part: as per the Physician Survey, which results are in Appendix 7, 
Portuguese physicians believe that advance directives should be part of an overall clinical 
process, or a patient autonomy tool, instead of an administrative instrument for reduction of 
costs. 
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WHAT CAN WE LEARN FROM THE AMERICAN MODEL? 
Lessons and recommendations  
There are important lessons and key recommendations that we can draw from more than forty 
years of experience in the US regarding advance health care and continuous work on end-of-
life care.  
There are many barriers to getting people to complete Advance Directives.
Advance directives are the embodiment of the principle of patient autonomy. They are intended 
to facilitate end-of-life decisions after incapacity. These directives aim to ensure that a patient’s 
wishes and preferences are followed in the event they are not able to make their own health care 
decisions194. They are meant to protect and respect patient’s dignity, promoting the well-being 
of the patient at the end of life. They may also offer some sort of comfort to family members, 
significantly reducing the stress and burden of making decisions for the patient195. 
Nonetheless, in spite of the early enthusiasm for advance directives and their envisioned 
benefits, in the US completion rates remain low. A systematic review of studies from 2011-
2016 found that “Among the 795,909 people in the 150 studies we analyzed, 36.7 percent had 
completed an advance directive”. According to this recent study, completion of these directives 
was slightly higher among patients with chronic illnesses (38.2%) than among healthy adults 
(32.7%), and it was much higher among elderly patients with more than sixty-five years old 
(45.6%) compared with younger adults (31.6%)196. There is consistent evidence that presently 
advance directives have low uptake and people are reluctant to do them. Two out of three 
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American adults have not completed an advance directive197.  Studies identify several barriers 
to advance directives completion198 to which Portugal and Macau may also be vulnerable.  
Reasons for non-completion can be on the side of the patient, due to lack of education or 
knowledge and difficulties with paperwork199. Another problem is fear and discomfort with the 
topic of death and dying. Talking about death is hard and problematic, especially when there is 
a terminal disease, as it involves thinking about deterioration of health and the process of 
dying200. One more limitation is the lack of physician initiative in bringing up the subject.  
Patients tend to believe that physicians are the ones that should start the conversation about 
end-of-life care planning201, and want their doctor to raise this topic202. 
Barriers to completing Advance Directives 
Physician-related 
 Discomfort with the topic 
 Lack of institutional support 
 Lack of reimbursement  
 Lack of time 
 Waiting for the patient to initiate the discussion 
Patient-related 
 Fear of burdening family or friends 
 Health literacy 
 Lack of interest or knowledge: “I don’t want to think about it” 
 Social isolation, lack of reliable proxy 
 Spiritual, cultural, and racial traditions 
 Waiting for the physician to initiate the discussion  
On the side of the physician, obstacles are mainly connected to reluctance to talk about end-of-
life care with patients due to the degree of emotional upset it may create. Physicians fear that a 
full disclosure of the patient’s prognosis may cause undue distress to the patient and that talking 
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about end-of-life issues may destroy hope for a positive outcome203. Time constraints of the 
health care providers in their daily medical practice should also be considered. The discussion 
of these directives is not only difficult and time-consuming, but also requires special 
training/skills. Billing for this service may also be a problem, raising reimbursement issues.204 
Legal requirements for witnessing205 and notarizing the directives may be too strict, becoming 
excessively burdensome and counterproductive for their completion206. Structural barriers 
include the lack of a formal system, like electronic health records indicating whether the patient 
has a directive. For example, in Portugal, registration of the directive in the National Registry 
is not compulsory. This makes difficult for medical providers to know if the patient has 
executed an advance directive. 
Cultural and ethnic factors also influence their completion207, as discussed. Because in Portugal 
and Macau religion and spirituality form the basis of meaning and purpose for the majority of 
people, options related to preferences of spiritual or religious needs and life-style may also be 
included in the text of the directives, as they serve as an important source of guidance. Although 
this is possible, it is not expressly stated in the Portuguese Law208. As discussed, under the 
North Carolina General Statutes, the patient may give instructions to the proxy regarding the 
disposition of remains and regarding burial or cremation. Details like this might be important 
for a Catholic who may prefer a burial in the ground, instead of a cremation. Moreover, Five 
Wishes is a user-friendly directive that merges both directives and tackles sensitive issues 
related to comfort measures, emotional suffering, spirituality and interpersonal needs.  
The living will has more shortcomings than benefits. The proxy is a better 
option. 
As currently implemented in the US, living wills are too vague and do not answer many of the 
specific questions that come up at the end of life. Most living wills do not give much detail 
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about treatments. They do not provide adequate guidance for the complexity of issues they try 
to address. These documents often include vague and ambiguous terms (e.g., terminal 
condition) and complex, technical language that demands interpretation. They are often 
insufficient to ensure that all decisions about end of life will be covered and made 100% in 
accordance with the patient’s wishes.  
The living will is not always useful in cases of chronic diseases209 that progress over a long 
period. Unpredictability of future situations and uncertainty connected with terminal medical 
conditions also makes decision-making difficult210. Additionally, there can be a problem 
accessing the documents in an emergency. Often the documents do not get into the medical 
records of the patient. Once executed they may be locked away in a safe deposit box or in a 
hidden place at home, becoming unavailable and useless when decisions need to be taken.211  
The appointment of a surrogate decision-maker is considered as a better option than a living 
will. The health care power of attorney is seen as a much more flexible and versatile 
instrument.212 Nevertheless, there are also a few reservations about proxy appointments. The 
appointed agent may later seem to be a wrong surrogate decision-maker, because when the time 
comes the surrogate may not want to bear the burden of such difficult task213. The proxy may 
have different beliefs than the patient and try to override the patient’s stated preferences, acting 
instead according to his or her own convictions/values214. The agent may also be not sufficiently 
involved in the patient’s health care plan215.  
Fear of the proxy/surrogate not entirely follow the patient’s wishes is another negative point. 
In Portugal, some voices argue that the law should have established in detail the powers that 
can be granted to the proxy216. At least an option to place limits should exist. Unfortunately, lay 
people often do not know enough about the medical setting to make reasonable choices about 
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limiting proxy powers. A combination of living will and appointment of a health care proxy 
may also be an alternative to address the complexities of end-of-life care.  
Notwithstanding the criticisms to both directives, someone has to make a decision. Having a 
directive, even with flaws, is better than not having a directive at all. Meaning that these 
instruments do not need to be perfect to be worthwhile. In spite of all shortcomings, it is 
important to give the authority to take medical decisions to someone the patient named and 
trusts, rather than a list that is set out in statute.  
Advance Directives are not just a form or a piece of paper.  
Forms alone generally do not work. Forms should foster communication and not be a substitute 
for it. Once end-of-life care instructions are written down on paper, people have the tendency 
not to mention it anymore. As such, simply informing patients about their rights to self-
determination and handing them the forms to fill out when admitted at the health care facility 
is not enough. A piece of paper will not suffice as a satisfactory means of doctor-patient 
communication.  Just completing a form will do patients little good if all the planning process 
is completely ignored. Planning is almost as important as screening and other forms of 
preventive health care.  
The American Bar Association (ABA) Committee on Law and Aging presented as one of the 
ten myths about health care advance directives, “Once I give my doctor a signed copy of my 
directive, my task is done!”217. This is false. Completing the directive is just a small part of an 
ongoing and multiple-step process of advance care planning218.  
Advance Directives should be reevaluated and updated periodically. 
It is impossible to know if patients will change their minds about intentions and plans for their 
end-of-life care so that advance directives become useless if not revised/updated. Wishes and 
values change over time and circumstances, depending on the progress of the disease219. It is 
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difficult to anticipate what the preferences of a patient will be in a future medical situation. 
Therefore, the directives can fail or may not have the desirable outcome if patients do not 
reevaluate and update them periodically.  
In Portugal, the Law establishes that the living will shall be valid for five years, renewable by 
means of a confirmation declaration. To establish that the directive is valid for a certain period 
of time reinforces the idea of updated consent220. This solution has been criticized, with authors 
arguing that five years is too long221. Having a limited time period may not be the best solution, 
though, because people may execute the living will and not re-execute it, leaving them with no 
directive. This may mean that they will receive more aggressive and even futile life-sustaining 
treatment.  
According to ABA, after preparing a living will, health care wishes should be re-evaluated 
whenever any of the Five Ds occur: “a new Decade in age, the Death of a loved one, Divorce, 
a Diagnosis of a significant medical condition, or a Decline in your medical condition.”222. Re-
examination of end-of-life care wishes according to other parameters, rather than only a time 
parameter, can be an alternative. Moreover, the review/revision should be a recommendation, 
and the document does not need to be considered necessarily invalid after a specified period of 
time. 
Advance Care Planning is an improvement over the traditional Directives. 
Advance care planning emerged as a concept worthy of attention in the context of end-of-life 
care, being an important improvement over the traditional directives223. Recognizing that 
medical decisions are complex and vary over time in the light of the disease progress, with 
suffering and pain playing an important role in the health care decisions, ACP was developed 
in the US as a continual process of communication and dialogue among physician and patient 
that goes beyond a mere written form or piece of paper224.  
                                                          
220 RAPOSO, VL (2011), p.181. 
221 MONGE, C (2014), p.155. 
222 At: https://www.americanbar.org/groups/health_law/news/2016/04/a_call_to_actionon.html. 
223 PERKINS, HS, (2007). 






Undeniably, advance care planning concept comprises advance directives, as they are 
documents in which the decisions coming from the ACP discussions can be recorded. Although 
talks are not legally binding, an ongoing physician-patient dialogue is the best guide for 
developing a personalized directive and to make sure end-of-life wishes are honored. ACP goes 
beyond the mere completion or execution of directives. Simply checking boxes on a form is of 
limited value as often patients need many conversations to consider their end-of-life pros, cons 
and options. Overcoming most of the completion barriers discussed above depends on an 
effective interactive discussion at multiple visits225, and on giving the patient the opportunity 
to ask questions226. ACP is today widely recognized in the US by being much more effective 
than standard directives alone in guaranteeing that patients’ preferences regarding end-of-life 
care are fully honored227.  
In Portugal, some criticisms of the Law are related to the fact that it stops shorts of compulsorily 
requiring health care providers to assist with the completion of an advance directive228. This is 
particularly important in relation to the living will, a document that gives rise to many 
preparation issues. The involvement of the physician can help to tailor the directive to the 
particular health situation of the patient. As such, there are doubts whether the preparation of a 
living will is indeed an exercise of informed consent without the physician giving the proper 
information, guidance and options available to the patient. Advance care planning could be 
effective in overcoming some of these difficulties. Although it does not serve exactly the same 
purpose as an advance directive, POLST is a good example of a tool that requires the 
physician’s229 direct involvement and signature. Considering that living wills are mainly 
executed by seriously ill people, why not think about these medical orders to at least 
complement the traditional directives? 
In Macau, to better accommodate cultural needs, lawmakers may have to consider the inclusion 
in future legislation of a provision establishing family members’ direct participation in the 
process of advance care planning. Taking into consideration the role of family members in 
health care decision-making, this ongoing communication process between physicians and 
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patients should be open to their families. Although it is imperative to ensure that patient 
autonomy is respected, the legal framework should simultaneously respect cultural traditions. 
Using a family covenant in planning end-of-life care maybe a solution230. In addition, when 
talking about death and dying is a taboo subject, encouraging patients to review and value their 
life experiences and complete unfinished business may help them to work on advance directive 
planning. A study on Chinese patients with advanced cancer revealed that encouraging patients 
to do a life review helps them to prepare for death231. 
Physicians need specific and ongoing education and training on end-of-life 
communication.
At least as an important recommendation based on the American experience, specific and 
ongoing education and training on advance care is essential for health care professionals who 
care for patients facing critical illnesses.232 Primary care physicians233 should also learn to 
initiate conversations about advance directives234. They should be aware of the existence of 
these directives and their legal standing, and be comfortable talking with their patients about 
end-of-life care. Education and training schemes in the graduate school curricula and after 
graduation, through simulation exercises, should focus on communication skills235.  
Communication interventions236 help physicians and nurses237 to improve their skills in 
discussing complex and sensitive end-of-life issues with patients238. It improves health care 
provider knowledge, comfort and self-confidence when discussing advance care. Conducting 
end-of-life conversations involves not only the logistics of directives preparation, the statement 
of wishes and/or the appointment of a proxy, but also a particular set of empathic and relational 
skills. Moreover, these conversations may also intersect with cultural, ethnic or religious beliefs 
that make the communication even more complicated.  
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Specific training for health care professionals is particularly important for the 
Chinese/Macanese. In Macau, education programs for health care professionals239 are mainly 
characterized by a strong medical orientation, giving little or no attention to psychosocial 
aspects of care, communication skills or education regarding death. As discussed, physicians 
are reluctant to discuss disease and death openly with patients. They often use all available 
measures to avoid death.240  Besides, physicians may tend to prolong life at any price so that 
will not to be accused of neglect (defensive medicine). Chinese doctors are not particularly 
communicative, and there is a sense of hierarchy that must be respected. Patients abide by the 
physician’s recommendations without questioning.  
Studies are a good source of information. 
Another key recommendation to be drawn from the American experience is that over the years, 
numerous studies, either randomized controlled trials or observational studies, have been 
performed in the US on end-of-life care and advance care planning, which are quite revealing 
and informative.  
Studies are particularly important in Macau where there is no specific law regarding advance 
directives. Before legislation is adopted in this Region, research studies should be conducted. 
If legislation is to be enacted, it should be consistent with Chinese culture and values and suit 
local demands, namely ethnicity and religion that bear a significant influence on health care 
decisions. As per Decree-Law no.7/99/M, February 19, the Ethics Council for the Life Sciences, 
is competent to study and present a preliminary approach as to the possible applicability of 
these directives and end-of-life planning in the Region. Local studies in different groups need 
to be performed to assess the acceptability of the directives. Research across nearby 
jurisdictions with different legislation and advance directives options is essential.  
Problems may arise as the concept might not be easily accepted in general by the Chinese 
population:  “people fear that openly acknowledging an impending death is like casting a death 
curse on a person, so to engage in discussions of any such code or an AD is viewed as courting 
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bad luck.”241. If acceptance is confirmed, community education programs should be initiated. 
It will certainly be a challenging mission due to the hybrid nature of the Region. 
Dissemination of ACP and Advance Directives is a task shared by many. 
Notwithstanding their low rate of completion, there is a role for advance directives (as they 
protect a patient’s right to self-determination), being widely advocated in the US, not only at 
state level, by the enactment of specific legislation242, but also at federal level through the 
Patient Self-Determination Act, requiring Medicare-certified facilities to provide for the 
dissemination of information on advance directives to the public243. Medical providers and 
health care institutions, including HMOs, promote the execution of advance directives and 
advance care planning. They have the endorsement of professional organizations, such as the 
American Medical Association, and of non-state entities, like Aging with Dignity. The Center 
for Disease Control and Prevention also recognizes their relevance in the public health context 
due to the increasing number of chronic diseases244. Physicians, ethicists, legislators, attorneys, 
all participated actively in the dissemination of advance care over the years. 
Even though directives seemed to some extent have failed, these instruments, as part of ACP, 
are desirable245 and should keep being offered as a solution. There are some strategies/initiatives 
to promote them and to encourage their execution, that would overcome the barriers referred in 
lesson one. As in the US, in Portugal this is a responsibility to be shared by many. At the top of 
the list is the National Health Service through the development of a multichannel 
communication strategy. It should provide funding for studies. Public awareness and 
informational campaigns are important to clarify what these instruments are and what they aim 
for. Public policy can develop effective ways to advance care planning become standard 
practice to health care providers and routine for adults (and be more than providing 
brochures/pamphlets). Attention should be first given to elderly and patients with chronic 
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the New York Palliative Care Information Act (2011).  
243 By the time the PSDA was introduced, roughly 9% Americans had actually executed a directive (at: 
https://www.finance.senate.gov/imo/media/doc/hrg101-1168.pdf, p.152); now, the rate increased to 
approximately 35%.  
244 BENSON, WF AND ALDRICH, N (2012), p.15. 






illness, like cancer and dementia. The Portuguese Association of Bioethics has been actively 
promoting advance directives and informing the public about the relevance of end-of-life plan. 
There may be ethical implications of ACP becoming a purely economic 
strategy.  
Last but not least: ACP may have the potential to affect overall health care costs. Such potential 
impact in containing costs may raise delicate ethical issues. Because of the increasing economic 
pressure to control health care expenditures due to the scarcity of resources, there may be 
concerns that cost considerations and motivations could unduly influence the free 
communication process between patient and physician, undermining patient autonomy. 
Moreover, if that occurs, it may be deemed too costly to society: “should people suspect they 
were being pressured to sign advance directives and that such directives might be used 
inappropriately to limit care, then the result might be both higher costs and more use of advance 
technology that patients or families would forego in an environment of greater trust.”246. 
In principle, the fee-for-service payment model makes it less likely that ACP could be used to 
ration care in the US than in Portugal. However, with the new Medicare billing code things may 
be slightly different. Although the idea was to address the problem of doctors not taking the 
time for important end-of-life conversations, some worry that health care providers will be 
compelled to make decisions based on costs - discouraging treatments or, worse, withholding 
them entirely - than on best medical care247. Yet, the fact that Medicare is paying at a low rate248 
for end-of-life conversations, might not in reality overcome the other big incentive to do more.  
Differently, in Portugal with a health care system subsidized mainly by the government, the 
fee-for-service incentive is not typically present. Advance care planning is essential to improve 
end-of-life quality and strengthen patient autonomy, but can easily be seen as a mechanism to 
save health care resources and money. Physician-patient end-of-life conversations have positive 
outcomes and should happen. People are encouraged to contemplate these decisions. However, 
if ACP is used only and explicitly to contain costs, there is a risk of patients’ decision-making 
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about end-of-life care be manipulated, causing a collision with their autonomy. While it is 
challenging to find an ethically feasible approach249 to any cost control/rationing measure in 
the health field (a social right protected by the Constitution), strong influence of Catholic 
thoughts/views – based on protection of life, human dignity and well-being - have a role in 
balancing the rationing concern.  
In any event, safeguards to guarantee the existence of a free and autonomous decision-making 
process should be put in place.250 Ongoing monitoring and research by the competent 
government body should assess whether ACP and directives do cause rationing and 
undermining of patient’s preferences. Education and training of health care providers that 
focuses on communications skills and specific knowledge (and certification) of advance care 
planning. The establishment of guidelines/standards to ensure the transparency and 
fair/openness of the decision-making process is another way to guarantee the care delivered at 
end-of-life is fully aligned with patient’s preferences.  
CONCLUSION      
Final thoughts 
The present work attempts to summarize and analyze the main outcomes in the US in respect 
to advance directives. It attempts to identify the main lessons learned from the American 
advance care model and a few recommendations based on the American experience. In order 
to improve older and sick adults’ quality of end-of-life care, it is worthwhile considering 
alternative practices used in the US. There are a few aspects that are unique to the US context, 
such as problems associated with lack of uniformity of state laws or the need for financial 
incentives for end-of-life conversations in a fee-for-service payment model.  
Nevertheless, Portugal and Macau may be to a great extent vulnerable to the same failures 
identified in the US, reflected in the poor uptake of advance directives by the public. Most of 
the barriers to completion and implementation of the living will identified in the US also have 
application in Portugal and Macau. The power of attorney is a more effective tool for patients 
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to plan for end-of life. It is a more gentle way to start thinking about end-of-life care. Besides, 
considering the important position of family in these decisions, it is more a matter of identifying 
who the patient trusts to make medical decisions on his or her behalf that will be the central 
spokesperson. 
As advance directives showed many limitations, ACP arises as a new improved paradigm. It 
refocuses attention away from a specific document to a wider and continuing process of 
communication that can and should be constantly revised vis-à-vis the changing of medical 
circumstances and of evaluation of illness, disability and suffering of the patient. However, 
advance care needs to be evaluated within specific cultural and social contexts. Religious 
affiliations are also linked with end-of-life preferences. Community-based programs – e.g., The 
Conversation-Project (2017) - may be a possible method to bring more awareness about end-
of-life care to the general population, better serving distinctive cultural, social, religious and 
language needs251.    
At the same time, advances in medical technology are undeniable. It allowed life-extension 
beyond anything that could ever have been imagined. We are facing worldwide a reality of an 
increasingly elderly population that needs more and special care, with inherent costs associated 
especially at the end of life. Advance directives that emerged to enhance patient’s autonomy 
and to help them take control of end-of-life care, contribute to setting limits and putting 
technology on hold.  
As nowadays there is an urgent call for health rationing and resource allocation, advance care 
planning promotes more appropriate care at the end of life and, at the same time, has – at least 
– some potential to reduce hospitalizations and to cut costs. However, some caution is warranted 
on promoting ACP as a cost-containment measure. If it is used for costs containment only, 
ethical dilemmas and medico-legal issues might emerge. As discussed, the intrinsic value of 
advance directives arose in Western societies from the notion of autonomy252 in an era of huge 
technological developments. In this respect, any type of financially motivated intervention 
should end once medical practice begins. Other criteria beyond what is the best for the patient 
from a clinical point of view, should not count in terms of medical decisions. As such, the use 
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of these directives specifically, and more broadly of advance care planning model, for cost 
control and equitable allocation of resources is only justified if it reflects patient’s authentic and 
genuine wishes.  
For the sake of patient autonomy, safeguards should be put in place. A multi-faceted approach 
that considers ACP completion along with proper clinician’s education/training is fundamental 
to deal with these sensitive issues. As once emphasized: “advance directives were designed to 
assure the private good, not the public (…) to give patients a safeguard against being 
overpowered by overzealous physicians or institutions”253.  
  
                                                          








The Natural Death Act, California Health & Safety Code (original text) 
§§7185-7195 (West Supp. 1977)254 
 
                                                          








Advance Directives Requirements and Formalities: North Carolina General Statutes 
Table 1. Living Will255 
Competence The declarant must have at least eighteen years old and be 
competent i.e., able to think rationally and to communicate his 
or her wishes clearly256. 
 
Effectiveness Once the declarant loses the capacity to consent or to refuse 
medical treatment, the physician can and should be guided by 
the directives. Lack of capacity typically includes cases of 
persistent vegetative state due to a severe injury or terminal 
illness. The directives may also apply to situations of temporary 
loss of consciousness and where patients suffers from a mental 
disease, like advanced dementia, compromising their ability and 
perception to make autonomous decisions. 
For life-prolonging measures257 be withdrawn or withheld, the 
attending physician must make a determination that the 
declarant is in one of the situations in which is authorized to 
withdrawal or withholding life-prolonging measures, followed 
by a second physician confirmation of this condition. Once the 
two physicians have concurred that the declarant is in one of the 
conditions in which is authorized to withholding or withdrawal 
life-prolonging measures, the attending physician will make 
specific medical orders to effect/implement the declarant 
desires. If there is a health care agent, the physician will be 




The declarant may decline life-prolonging measures, if is alert 
and can make his or her own medical decisions. If is not 
competent, he or she can rely on the directives in the living will. 
There are tree situations in which the declarant may, in advance, 
decline life-prolonging measures: i) has an incurable or 
irreversible condition that will result in the declarant's death 
within a relatively short period of time; or ii) becomes 
unconscious and, to a high degree of medical certainty, will 
never regain consciousness; or iii) suffers from advanced 




                                                          
255 North Carolina’s Right to a Natural Death Act (§ 90-320 through 90-322), at: 
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vital function, including mechanical ventilation, dialysis, antibiotics, artificial nutrition and hydration, and similar 
forms of treatment. Life-prolonging measures do not include care necessary to provide comfort or to alleviate 
pain.”. It is important to distinguish life-prolonging measures from artificial hydration and nutrition. Although 
some patients would like to withdraw mechanical ventilation/respirator, they would still want to receive artificial 






dementia or any other condition resulting in the substantial loss 
of cognitive ability and that loss, to a high degree of medical 
certainty, is not reversible. 
The living will may operate in conjunction with a health care 
power of attorney. When both work together, the documents 
must be consistent with each other. If both directives are in 
operation, it is possible to leave the decision to the health care 
agent, especially if the declarant does not have strong feelings 
on what to do in terms of future medical treatment and feels 
uncomfortable about projecting what the circumstances may be 









The living will must be prepared in writing and signed by the 
declarant in the presence of two258 qualified witnesses and a 
notary public. In order to be a witness some criteria need to be 
met: i) the witness must have at least eighteen years old; ii) is 
not an employee of the health care facility that treats the patient; 
iii) is not a person who would inherit under a will or intestate 
succession. A signed copy of the living will should be given to 
each of the declarant’s physicians and to any medical facility 
involved to be included in the patient’s medical chart. It is also 
possible to register the directive with the North Carolina 
Secretary of State.  
Health care providers normally use a standardized State form 
that a patient fills out with his or her own medical care wishes. 
A hospital will be able to provide a form prepared according to 
the law. North Carolina forms are available on the Internet, 
through the North Carolina Secretary of State259. 
§ 90-
321(c)(3),(4) 
Revocation The living will may be revoked by the declarant “in writing or 
in any manner by which the declarant is able to communicate 
the declarant's intent to revoke in a clear and consistent manner, 
without regard to the declarant's mental or physical condition.”. 
These directives will remain valid during declarant’s lifetime 
unless he or she revokes260 or unless a specific time limit is set 










When an individual does not plan for incapacity by preparing a 
directive, physicians need to seek a decision-maker. Normally, 
family members are left with the burden of making such difficult 
decisions261. In case an individual does not plan for incapacity, 
the North Carolina General Statutes establish a list of persons to 
whom physicians should turn to: spouse, parents, adult child, 
siblings, and close friend. 
 
                                                          
258 In almost all States, at least two witnesses are required. Some States do not require notarization.  
259 At: https://www.sosnc.gov/divisions/advance_healthcare_directives.  
260 HEALTH JUSTICE CLINIC DUKE MANUSCRIPT (2016). 






Procedure The law establishes a procedure for removal of life-prolonging 
measures when the person is near death. Firstly, the physician 
must determine to a high degree of medical certainty, that the 
patient lacks capacity to make or communicate health care 
decisions, and that the patient will never regain that capacity. 
Secondly, the same physician must determine that the patient is 
in one of the following physical conditions: “a. Has an incurable 
or irreversible condition that will result in the person’s death 
within a relatively short period of time; or b. Is unconscious and, 
to a high degree of medical certainty, will never regain 
consciousness;” Thirdly, a second physician must concur in 
writing that the patient is in this condition and “A vital bodily 
function of the person could be restored or is being sustained by 
life-prolonging measures;”.  
If the patient meets all the conditions mentioned above, then 
life-prolonging measures may be withheld or discontinued upon 
the direction and under the supervision of the attending 
physician with the concurrence of the following persons: i) a 
legal guardian; ii) an health care agent, to the extent of authority 
granted; iii) an attorney-in-fact under a general power of 
attorney who has been given power to make health care 
decisions, to the extent authority granted; iv) the patient’s 
spouse; v) a majority of the patient’s reasonably available 
parents and children who are at least eighteen years old; vi) a 
majority of the patient’s reasonably available siblings who are 
at least eighteen years old; vii) an individual who has an 
established relationship with the patient, who is acting in good 
faith on behalf of the patient, and who can reliably convey the 
patient’s wishes. Moreover, “If none of the above is reasonably 
available then at the discretion of the attending physician the 
life-prolonging measures may be withheld or discontinued upon 














Table 2. Health Care Power of Attorney262 
Competence The principal must have eighteen years old and be mentally 
competent: “Any person having understanding and 
capacity to make and communicate health care decisions, 
who is 18 years of age or older, may make a health care 
power of attorney.”.  
As for the agent, “Any competent person who is not 
engaged in providing health care to the principal for 





                                                          







as a health care agent.” It can be, but do not need to be the 
same person appointed as attorney in fact to make financial 
decisions on behalf of the patient. The principal may also 
name alternate(s) health care proxies. 
§ 32A-18 
Effectiveness It becomes effective when the physician establishes in 
writing that the patient “lacks sufficient understanding or 
capacity to make or communicate decisions relating to the 
health care of the principal and shall continue in effect 
during the incapacity of the principal”; in case there is not 





Broad powers are granted in terms of health care decisions, 
being the principal able to limit the grant of such powers 
(e.g. blood transfusions limitations). The principal may 
include powers to make decisions regarding end-of-life 
care as well. Instead of withholding or withdrawing life 
prolonging measures, it may establish maximum treatment. 
It is also possible to incorporate an advance instruction for 
mental health treatment, for specific mental health 
treatments. Access to private health information about the 
patient is also possible to include in the document text. 
Organ donation, autopsy and disposition of remains are as 
well matters that can be covered by this directive.  
§ 32A-19 
Requirements  The power of attorney must be prepared in writing and 
signed by at least two qualified witnesses (criteria to be a 
witness is the same as above) and acknowledged before a 
notary public. A copy of the signed directive should be 
given to the physician of the principal and any medical 
facility involved to be included in the patient’s medical 
chart. It should also be delivered to the agent appointed (or 
at least the health care agent should be informed of where 
the document can be found). It is possible to register the 





Revocation  The directive “may be revoked by the principal at any time, 
so long as the principal is capable of making and 
communicating health care decisions”. Revocation is 
effective upon communication to the health care agent(s) 
and to the principal’s attending physician. Except in 
relation to anatomical gifts, disposition of remains, and 
autopsy, power of attorney is also revoked by the death of 
the patient.  








Table 3. Guardianship263 
Guardianship If statutory decision makers cannot agree and are in conflict 
about the patient’s wishes, it may become necessary for the 
appointment of a legal guardian, i.e., a person who has the 
authority and duty to care for another’s person or property. 
Each State has its own rules on the requirements and 
process for the appointment of a legal guardian. In North 
Carolina, the law requires first the determination by the 
Clerk of Superior Court that the patient is legally 
incompetent. If incompetence is found and determined, a 
suitable guardian must be chosen for the incapacitated 
person, and his or her authority duly specified.   
§35A-1101 
et seq. 
 The decision to pursue guardianship should not be taken 
lightly as it is often a time-consuming process and it 
involves removing of an individual’s rights. It should be a 
last resort option especially in an end-of-life situation in 
which decisions may need to be made very quickly. 
Guardianship implies a court procedure and cannot happen 
in a matter of hours or days. It can be workable in a less 
emergency, such as Karen Quinlan case, where the patient 
was in a long-term persistent vegetative state, so time is not 


















                                                          









Main Components of the Portuguese Living Will Law  
Law no.25/2012, from July 16264  
1- LIVING WILL 
The living will may specifically include the following: i) refuse artificial support of vital 
functions; ii) refuse futile, useless, disproportioned treatment265, according to good medical 
practice, namely in relation to basic life-support and artificial feeding and hydration that only 
aim to delay the natural process of dying; iii) receive adequate palliative care, including 
symptomatic therapy in case of serious and irreversible illness; iv) refuse experimental 
treatments; and, v) authorize or refuse to participate in scientific research or clinical trials; 
(Article 2, number 2)266,267. Hence, the living will serve two purposes, either to refuse or to 
expressly request certain medical treatments. 
The living will must comply with the requirements stated by law, including the formal ones. 
As for the formal aspects, the living will should be in writing, and signed in the presence of 
an official from the Living Will National Registry or a notary (Article 3, number 1)268). The 
patient may request the cooperation of a physician in the elaboration of the document 
(number 2). Participation of the physician is not compulsory. By Ordinance no.104/2014, 
of May 15269, the Ministry of Health approved an advance directive optional form. Moreover, 
a form is also provided by the National Health System (RENTEV)270. Although at first 
glance Portuguese law seems too formal, it applies a principle of freedom of form271. 
The Statute establish some legal limits to the directives (Article 5). For example, whenever 
the directive is found to be contrary to the law or against good medical practices, it shall not 
have any legal effect. Directives that take to non-natural and preventable deaths are strictly 
                                                          
264 At: http://data.dre.pt/eli/lei/25/2012/07/16/p/dre/pt/html. 
265 This provision covers the situations of dysthanasia (SANTOS, ECC (2014), pp.105-113).  
266 This is an exemplificative list only. Directives should not contain requests for euthanasia or assisted suicides 
that are against the law. 
267 Organ donation is not included in this list. In Portugal, all citizens are organ donors, unless the contrary is 
expressly stated by registering in the National Registry for Non-Donors.  
268 There are no witness requirements.  
269 At: http://data.dre.pt/eli/port/104/2014/05/15/p/dre/pt/html. 
270 At: http://spms.min-saude.pt/wp-content/uploads/2016/05/Rentev_form_v0.5.pdf. 







forbidden, as prescribed in Article 134 (‘homicide by request of the victim’) and Article 135 
(‘Induction/instigation or suicide aid’) of the Criminal Code.   
If there is a directive duly executed272, the medical team shall follow the wishes/preferences 
previously stated in the document (Article 6, number 1). The directive applies once the 
patient becomes incapable273. If a physician does not comply with a directive validly 
executed and binding, he or she will be charged with a crime of arbitrary medical-surgical 
procedure under Article 156 of the Criminal Code274. However, the medical team may not 
follow the directive if it can be demonstrated that the patient would not want the directive to 
be respected anymore, if the directive is clearly outdated given the progress of medical 
technology, and if the directive does not correspond to the circumstances foreseen at the time 
of its execution (number 2). Moreover, the directive may not be respected in cases of 
emergency or of immediate danger to the patient’s life (number 4). A medical decision taken 
on the basis of a directive shall be documented in the patient’s medical chart (number 5). 
The living will shall be valid for five years, renewable for equal and successive periods by 
means of a declaration of confirmation by the principal (Article 7, numbers 1 and 2). The 
living will can be revoked and modified at any time (Article 8). Conscientious objection 
may be invoked by health care providers in some circumstances. Health care professionals 
can refuse, on grounds of conscience, to withhold or withdraw a treatment that can lead to 
the death of a patient (Article 9). A non-discrimination principle is set forth in Article 10.  
2- HEALTH CARE POWER OF ATTORNEY 
The health care power of attorney is specifically regulated in Articles 11 to 14 of the Law. 
Capacity requirements of the proxy are established in Article 11, number 2. Two proxies 
may be appointed, a primary and an alternative one (Article 11, number 5). The health care 
power of attorney must be in writing. It is applicable to the health care power of attorney, 
with necessary adaptations, the provisions of Articles 262, 264 and 265, number 1 and 2 of 
the Civil Code (related to the powers of attorney). The decisions taken by the health care 
proxy shall be respected by the health care providers (Article 13, number 1). The Law also 
allows a combination of these directives. If there is a conflict between a living will and the 
                                                          
272 If it was not executed, the physician should determine the patient hypothetic/presumed will. Family and close 
friends of the patient play a significant role in the decision making process and should be listened by the doctor 
(MONGE, C (2014), p.216). 
273 It is applicable not only when the patient is unconscious, but also when is conscious but suffers from a mental 
disease, such as Alzheimer, that impair the individual’s decision-making capacity (SANTOS ECC (2014), p.118). 






health care power of attorney, the wishes stated in the living will shall prevail. (Article 13, 
number 2). It may be freely revoked by the principal/patient (Article 14, number 1). 
3- LIVING WILL NATIONAL REGISTRY 
Article 15 created the Living Will National Registry (RENTEV), which was subsequently 
regulated by the Health Ministry by Ordinance no.96/2014, of May 15275.  Registration is 
merely declarative. It is not a condition for the validity and efficacy of the directives (Article 
16). If the living will and/or the health care power of attorney was executed, the respective 
document is attached to the patients’ medical chart (Article 17, number 2). Confidentiality 




                                                          







Living Will National Registry (RENTEV) Information  
Number of Living Wills registered in Portugal as of February 4, 2018276 (organized by gender 
and age group) 277. 
 Men  Women Total 
[18 ~ 25] 229 280 509 
[25 ~ 35] 512 782 1294 
[35 ~ 50] 1473 2190 3663 
[50 ~ 65] 1594 3339 4933 
[65 ~ 80] 2136 4380 6516 
>= 80 years 
old 
584 1310 1894 
 6528 12281 18809 
For additional information on the topic (by year and month), check the dashboard: 
https://www.sns.gov.pt/monitorizacao-do-sns/testamento-vital/. 
 
                                                          
276 This information was provided, upon request, by email from the National Health System dated from February 
14, 2018. 







Survey Questionnaire: Table & Key Findings 
I. TABLE: DATA COLLECTION 






Total number of 
respondents 
 8 21 10 
Gender  M 1 8 3 
F 7 13 7 
Age 25-34 2 6 8 
35-44 --- 12 --- 
45-54 1 1 --- 
55-64 2 2 2 
65-74 3 --- --- 
Ethnicity  White/Caucasian 7 21 --- 
Asian --- --- 10 
Other 1 --- --- 
Education  High school graduate  1 --- 1 
Technical training  --- 2 --- 
Bachelor’s degree --- 6 3 
Master’s degree 6 13 6 
Doctorate degree 1 --- --- 
Religion  Christian --- 1  
Catholic 2 9 4 
Buddhist  1 --- 1 
Atheist 1 --- --- 
Agnostic 1 2 --- 
Non-religious  3 9 5 
Overall health 
status 
Very poor --- --- --- 
Poor --- --- --- 
Fair --- 3 4 
Good 6 4 6 




I do not want to talk 
about it 
--- 5 --- 
I prefer to leave it in 
God’s hands 
--- 4 5 
I do not accept death --- 1 --- 
I am comfortable 
with the subject 
8 11 4 










Gave a correct / 
approximate 
definition 





8 1 7 
Not aware of the 
content  




Yes, know about it 7 6 --- 
No, have no idea  2 15 10 
Planning/discussio




Yes, have discussed  1 -- --- 
No, but would like to 
have such 
conversation 
5 12 7 
No, and would not 
like to have such 
conversation 
2 7 3 
The doctor took the 
initiative  
2 --- --- 
The doctor has not 
taken the initiative  





in all scenarios:  
Coma with small 
chance of recovering; 
persistent vegetative 
state (PVS); 
dementia with no 
other life threatening 
illness; dementia 
with a life 
threatening illness   




3 5 2 
Keep artificial 
nutrition/hydration  
4 13 7 










With a formal AD 
executed  
5 --- --- 
Without a formal AD 
executed 
3 21 10 
Surrogate decision 
maker preference 
3 5 4 







II. KEY FINDINGS278  
 
1- US: American respondents279 
All know what an advance directive is. The majority already have a directive formally 
executed, either in the form of a living will or of a health care power of attorney, being 55-
64/65-74 years old and in good/excellent health condition. One respondent mentioned that they 
have already discussed the subject in detail with their spouse. Only one has talked specifically 
about advance directives with his or her physician. Generally, all would like the physician to 
take the initiative of bringing up the topic. In one situation, the doctor took the initiative of 
talking about these directives, and in other, the doctor just gave a pamphlet with information. 
A small number of respondents will forego life-sustaining measures in all scenarios, i.e., coma 
with small chance of recovering, persistent vegetative state, dementia with no other life 
threatening illness, and dementia with a life threatening illness. One respondent expressly 
wrote “NOTHING ARTIFITIAL. NO HOSPITAL STAY”. Another wrote that they want to 
have “quality of life”. One respondent stated, in relation to the withdrawal of artificial nutrition 
and hydration, “This would depend upon my condition! I don’t want to be starved to death!”.  
When asked about their feelings and thoughts concerning death or an illness that may turn them 
completely incapacitated, either physically or mentally, all answered that they are comfortable 
with the subject. One of the respondents is African American/Caribbean, although not affiliated 
with any religion in particular (this respondent has already a directive formally executed). 
Almost all respondents answered that they are non-religious or non-practicing people, agnostic 
or even atheist.   
                                                          
278 Conducted for the purposes of this Master Thesis during January of 2018. 
279 To complement my findings, during my experience in the US, I observed that all clients of the Health Justice 
Clinic were well informed about advance directives, inclusively low-income African-American women living with 
HIV, who previously had a conversation with their health care provider about the subject. My clients, a Caucasian 
elderly couple in their eighties and an HIV sixty year-old man, were also well informed about the existence of 
these instruments and their content. During the legal meetings, it was easy to talk about topics of death, terminal 
diseases and end-of-life plan. 
Family should take 
the burden  
8 13 9 
Personal views of 
planning for 
medical care at 
the end of this 
survey  
The participation on 
the survey changed 
the views on advance 
care planning 
4 7 6 
Will have an advance 
directive in the near 
future 






One respondent mentioned that they have no preference in appointing a surrogate decision-
maker or in having a living will. One wrote in the questionnaire, “But why not both?”. They 
all have mentioned that it would not be asking too much of their family to decide on these 
matters. In cases where the respondent indicated that they would opt for a surrogate decision-
maker, almost all said they would choose their spouse, a sibling, or an adult son/daughter. One 
commented that, “it is part of life, they must face the truth”. For half of participants, their 
participation in the survey changed their views on advance care planning. One respondent 
expressly noted, “This is making me realize that I need to do something. I think I will have the 
conversation. I would not guess a timeline for getting it done”. 
 
2- Portugal: Portuguese respondents  
Half of the respondents are comfortable with the subject. Four respondents, mainly Catholic, 
put their trust in God on these issues. Five answered that they do not want to talk about the 
topic, and one does not accept death. Almost all respondents are not aware of the content of 
these directives, with nearly half giving a correct or just a mere approximate response of what 
an advance directive is. Only six of a total of twenty-one respondents know about the existence 
of specific legislation regulating these directives. It is important to mention that all of them 
have at least a bachelor’s or master’s degree. Only one had correctly identified the specific law 
that regulates advance directives.  
Zero respondents have ever discussed with their doctor which life-sustaining treatments they 
would want to pursue if they become so ill that they would not be able to make the decisions 
by themselves. The majority answered that they would like to have a discussion with their 
physician about advance directives. Only four would forego life-sustaining measures in all 
scenarios: coma with small chance of recovering, persistent vegetative state, dementia with no 
other life threatening illness, and dementia with a life threatening illness. Only five would 
forego cardiopulmonary resuscitation, assisted ventilation and artificial nutrition. The majority 
of respondents would like to keep artificial nutrition and hydration.  
The majority would feel more comfortable to have a formal statement in the form of a living 
will stating their wishes directly to the physician. The main reasons for that are: “Because some 
decisions should not be left to other people to make,” “Not to burden someone with such a 
difficult decision”, “to make sure that what I want is followed” and, “I can’t think of a proxy”. 
Almost all respondents consider that it is not asking too much of their family to decide on these 






they had a conversation with their parents about end-of-life care wishes. The participation in 
the survey has not changed the views of most participants regarding end-of-life planning, and 
only a small number said they might prepare an advance directive in the future.  
 
3- Macau: Chinese/Macanese respondents  
Half of the respondents answered they would prefer to leave matters related to death and 
terminal illness in God’s hands. The other half is comfortable with the subject. One considers 
the subject matter irrelevant. The majority gave an approximate answer of what an advance 
directive is, which is a good input in terms of knowledge (the majority have a bachelor’s or 
master’s degree and work in the health care field). However, almost all consider that these 
documents often have dense legal wording, making them difficult to read and interpret.  
None of the respondents know about the existence of specific legislation in the Region that 
regulates advance directives. None has ever talked with his or her doctor about life-sustaining 
treatments, and none has ever formally executed an advance directive. The majority would like 
the doctor to initiate the conversation about the matter. The majority would like to forego life-
sustaining measures in all referred scenarios. Only two replied that they would like to 
withdraw/withhold cardiopulmonary resuscitation, assisted ventilation and artificial nutrition 
and hydration. Almost all would like to keep the option of artificial nutrition and hydration, so 
they would not be left to starve.  
While half of respondents would appoint a surrogate decision-maker, the other half would like 
to have a formal statement in the form of a living will.  Except for one respondent, all would 
like to appoint a family member (spouse, sibling or parents), as a proxy for this purpose. The 
majority recognize that this type of decision entails a considerable burden to their family, being 
however their responsibility. Almost all noted that the participation in this survey changed their 
views on their wish to have an advance directive, or at least to engage in a conversation with 
their doctor about the subject. However, only a few respondents recognized they would 









Health Care Expenditure: World Data & Charts 
1- US280 national health expenditure as % of GDP from 1960 to 2017281 
 
2- Portuguese282 health spending as a share of GDP in 2013283 
 
                                                          
280 In the US, health care is mainly funded by private insurance through employer, single-payer Medicare for those 
with 65 years old and older, and State managed Medicaid for low-income people. There is also private insurance 
through exchanges established by the Affordable Care Act. However, there are approximately 28 million people 
without any type of health insurance (at: https://www.cdc.gov/nchs/fastats/health-insurance.htm). 
281 At: https://www.statista.com/statistics/184968/us-health-expenditure-as-percent-of-gdp-since-1960/. 
282 In Portugal, health care is delivered by three co-existing systems. While one is universal (for everyone that 
contributes to social security, plus their families and retirees), the other two are characterized by encompassing 
both private and public health care providers and different levels of cost sharing. 






3- Portuguese government (public) total expenditure on health in 2015284 
 
4- Health expenditure, public (% of GDP): comparison between US, Portugal and PRC 
(Mainland China)285  
 
                                                          
284 At: http://ec.europa.eu/eurostat/web/products-eurostat-news/-/DDN-20170825-1. 
285 At: https://data.worldbank.org/indicator/SH.XPD.TOTL.ZS?locations=PT-US-CN. There is no data available 
for the MSAR. In Macau, health expenditure has been increasing. From about 3.78 billion MOP in 2011, it has 
raised up to 6.32 billion MOP in 2016. Macau local residents benefit from a public type of financing health care 
system, which coexists with a private financing by two forms: health care subsidy scheme or cooperation with 








Physicians Survey Questionnaire: Charts & Findings 
I. CHARTS  
i) Opinion/attitude toward advance                ii) What type of advance directive 
directives                                               is preferred? 
                   
iii) Main advantage of advance        iv) Experience in medical 
directives                                   practice of advance directives 







v) Who should be offered an advance        vi) Knowledge of legal standing 
directive?                       on advance directives 
            
vii) What strategies will encourage        viii) What is the most appropriate 
physicians to offer advance directives?        answer? 








This survey was conducted to examine the attitudes toward the experience with, and the 
knowledge of, advance directives of physicians in Portugal. It was conducted during February 
of 2018 with a target of approximately twenty physicians, having ten respondents only, from 
general practitioners to different medical specialties, such as psychiatry, ophthalmology, 
internal medicine, rheumatologist, etc. Graduation dates range from 1976 to 2014.      
According to the Survey: 
 Respondents are mainly in favor of the use of advance directives (70%), with 30% 
reporting they strongly agree with their use. No physicians opined against the use of the 
Directives.  
 Regarding the type of advance directives preferred, 70% of the respondents prefer a mix 
directive comprising both instruction and proxy components. While 20% are in favor of 
the living will, only 10% prefers the health care power of attorney. 
 For physicians, the main advantage of advance directives is allowing for patient autonomy 
in decision-making. Only one answered that the directives reduce family anxiety and 
discord. No one answered that advance directives’ main benefit is to contain unnecessary 
medical expenditure. 
 In relation to experience of these directives in medical practice, the majority (i.e., 70%) 
answered they have never had experience using a directive in a clinical situation. In turn, 
30% of the respondents had encountered at least once a patient with an advance directive. 
There were no answers in the option “frequently to always use advance directives on 
medical practice”. 
 Seven respondents consider that advance directives should be offered to all adult patients, 
both healthy and non-healthy. Three are of the view that these directives should be offered 
to the terminally and chronically ill patients only. No one considers that advance directives 
should be offered to patients admitted in the Hospital through the emergency department. 
 In respect to knowledge of legal standing of advance directives, at least four respondents 
are aware of the existence of a law dated from 2012 that specifically regulates advance 
directives. Six of them are not aware of specific legislation in Portugal on the topic. Two 
physicians have indicated correctly the Law no.25/2012 (i.e., the Living Will Law). 
 What strategies will encourage physicians to offer advance directives to their patients? One 
physician answered “specific legislation”, two of them opted for “hospital policy requiring 






admission”, and seven had chosen the option “professional education about advance 
directives”. No one opted out for “reimbursements for time spent with patients discussing 
advance directives”. 
 As for the last question, the majority (i.e., 80%) of the respondents answered that advance 
directives are part of an overall clinical process, and two of them specifically answered that 
advance directives are a patient autonomy tool. There were no respondents answering that 
these directives should be an administrative tool to reduce health care costs. 
The Survey only provides a very small sample of views of Portuguese physicians in respect to 
advance directives. Answers provided should be observed and evaluated with caution. Among 
the medical specialties, there are no physicians from oncology or neurological areas, which can 
be a limitation in terms or results, if we consider that physicians that care for patients with acute 
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